Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2019 | May 29, 2020 | Jun. 28, 2019 | |
Cover [Abstract] | |||
Document Type | 10-K/A | ||
Amendment Flag | true | ||
Amendment Description | The sole purpose of this Amendment to the registrant’s Annual Report on Form 10-K for the period ended December 31, 2019 is to furnish revised Interactive Data File exhibits pursuant to Rule 405 of Regulation S-T. No other changes have been made to the 10-K, and this Amendment has not been updated to reflect events occurring subsequent to the filing of the 10-K. | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2019 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2019 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 333-149000 | ||
Entity Registrant Name | Astro Aerospace Ltd. | ||
Entity Central Index Key | 0001425203 | ||
Entity Tax Identification Number | 98-0557091 | ||
Entity Incorporation, State or Country Code | NV | ||
Entity Address, Address Line One | 320 W. Main Street | ||
Entity Address, City or Town | Lewisville | ||
Entity Address, State or Province | TX | ||
Entity Address, Country | US | ||
Entity Address, Postal Zip Code | 75057 | ||
City Area Code | 972 | ||
Local Phone Number | 221-1199 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 17,791,155 | ||
Entity Common Stock, Shares Outstanding | 78,129,504 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Dec. 31, 2019 | Dec. 31, 2018 |
Assets | ||
Cash | $ 1,159 | $ 55,129 |
Other Receivables | 60,517 | 32,657 |
Prepaids | 623 | 19,190 |
Total Current Assets | 62,299 | 106,976 |
Acquired In-Process Research and Development | 871,000 | 871,000 |
Deposits | 13,925 | 14,199 |
Total Assets | 947,224 | 992,175 |
Current Liabilities | ||
Accounts Payable and Accrued Liabilities | 265,604 | 93,952 |
8% Senior Secured Convertible Promissory Note, net of discounts of $289,093 and $592,932 at December 31, 2019 and 2018 | 694,431 | 108,886 |
8% Senior Secured Convertible Promissory Note issued December 2, 2019, net of discounts of $125,453 at December 31, 2019 | 24,093 | |
Total Current Liabilities | 984,128 | 202,838 |
Long Term Liabilities | ||
Promissory Note from MAAB | 750,017 | 591,439 |
Total Liabilities | 1,734,145 | 794,277 |
Stockholders' (Deficit) Equity | ||
Series A Convertible Preferred Stock, $0.0001 par value, 50,000,000 Shares Authorized, 1,562,500 shares Issued and Outstanding at December 31, 2019 and 2018; Series B Convertible Preferred Stock, $0.001 par value, 10,000 Shares Authorized, 10,000 Shares Issued and Outstanding at December 31, 2019 and 2018 | 166 | 166 |
Common Stock, $0.001 par value, 250,000,000 Shares Authorized, 73,201,722 and 69,308,946 shares Issued and Outstanding at December 31, 2019 and 2018 | 73,202 | 69,309 |
Additional Paid-in Capital:Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock | 9,476,684 | 8,117,521 |
Accumulated Other Comprehensive (Loss) Income | (20,098) | 22,704 |
Accumulated Deficit | (10,316,875) | (8,011,802) |
Total Stockholders' (Deficit) Equity | (786,921) | 197,898 |
Total Liabilities and Stockholders' (Deficit) Equity | 947,224 | 992,175 |
Additional Paid-In Capital Series A Preferred Stock [Member] | ||
Stockholders' (Deficit) Equity | ||
Additional Paid-in Capital:Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock | 124,844 | 124,844 |
Total Stockholders' (Deficit) Equity | 124,844 | 124,844 |
Total Liabilities and Stockholders' (Deficit) Equity | 124,844 | 124,844 |
Additional Paid - In Capital Series B Preferred Stock [Member] | ||
Stockholders' (Deficit) Equity | ||
Additional Paid-in Capital:Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock | 7,156,204 | 7,156,204 |
Total Stockholders' (Deficit) Equity | 7,156,204 | 7,156,204 |
Total Liabilities and Stockholders' (Deficit) Equity | 7,156,204 | 7,156,204 |
Additional Paid - In Capital Common Stock [Member] | ||
Stockholders' (Deficit) Equity | ||
Additional Paid-in Capital:Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock | 2,195,636 | 836,473 |
Total Stockholders' (Deficit) Equity | 2,195,636 | 836,473 |
Total Liabilities and Stockholders' (Deficit) Equity | 2,195,636 | 836,473 |
Series A Convertible Preferred Stock [Member] | ||
Stockholders' (Deficit) Equity | ||
Series A Convertible Preferred Stock, $0.0001 par value, 50,000,000 Shares Authorized, 1,562,500 shares Issued and Outstanding at December 31, 2019 and 2018; Series B Convertible Preferred Stock, $0.001 par value, 10,000 Shares Authorized, 10,000 Shares Issued and Outstanding at December 31, 2019 and 2018 | 156 | 156 |
Total Stockholders' (Deficit) Equity | 156 | 156 |
Total Liabilities and Stockholders' (Deficit) Equity | 156 | 156 |
Series B Convertible Preferred Stock [Member] | ||
Stockholders' (Deficit) Equity | ||
Series A Convertible Preferred Stock, $0.0001 par value, 50,000,000 Shares Authorized, 1,562,500 shares Issued and Outstanding at December 31, 2019 and 2018; Series B Convertible Preferred Stock, $0.001 par value, 10,000 Shares Authorized, 10,000 Shares Issued and Outstanding at December 31, 2019 and 2018 | 10 | 10 |
Total Stockholders' (Deficit) Equity | 10 | 10 |
Total Liabilities and Stockholders' (Deficit) Equity | $ 10 | $ 10 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2019 | Dec. 31, 2018 |
Common stock, shares authorized | 250,000,000 | 250,000,000 |
Common stock, par value per share | $ 0.001 | $ 0.001 |
Common stock, shares issued | 73,201,722 | 69,308,946 |
Common stock, shares outstanding | 73,201,722 | 69,308,946 |
Series A Convertible Preferred Stock [Member] | ||
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, par value per share | $ 0.0001 | $ 0.0001 |
Preferred stock, shares issued | 1,562,500 | 1,562,500 |
Preferred stock, shares outstanding | 1,562,500 | 1,562,500 |
Series B Convertible Preferred Stock [Member] | ||
Preferred stock, shares authorized | 10,000 | 10,000 |
Preferred stock, par value per share | $ 0.001 | $ 0.001 |
Preferred stock, shares issued | 10,000 | 10,000 |
Preferred stock, shares outstanding | 10,000 | 10,000 |
Consolidated Statements Of Oper
Consolidated Statements Of Operations - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Income Statement [Abstract] | ||
Revenue | ||
Operating Expenses: | ||
Sales and Marketing | 232,084 | 60,487 |
General and Administrative | 369,538 | 188,789 |
Research and Development | 545,639 | 901,857 |
Impairment Expense | 6,285,214 | |
Total Operating Expenses | 1,147,261 | 7,436,347 |
Loss from Operations | (1,147,261) | (7,436,347) |
Other Expense (Income) | ||
Interest Expense, Net | 1,316,407 | 318,038 |
Bank and Financing Fees | 19,799 | 23,147 |
Miscellaneous Income | (178,394) | (10,000) |
Total Other Expense | 1,157,812 | 331,185 |
Loss Before Income Tax | (2,305,073) | (7,767,532) |
Income Tax | ||
Current | ||
Deferred | ||
Loss from Continuing Operations, Net | (2,305,073) | (7,767,532) |
Discontinued Operations: | ||
Income from Discontinued Operations | 178,300 | |
Income Tax | 37,367 | |
Income from Discontinued Operations, Net | 140,933 | |
Net Loss | (2,305,073) | (7,626,599) |
Less: Preferred Stock Dividends | 10,000 | 10,000 |
Net Loss Available to Common Stockholders | $ (2,315,073) | $ (7,636,599) |
Net Loss From Continuing Operations per Common Share: | ||
Basic | $ (0.03) | $ (0.11) |
Diluted | (0.03) | (0.11) |
Net Earnings From Discontinued Operations per Common Share: | ||
Basic | ||
Diluted | ||
Net Loss per Common Share: | ||
Basic | (0.03) | (0.10) |
Diluted | $ (0.03) | $ (0.10) |
Weighted Average Number of Common Shares Outstanding - Basic | 71,297,272 | 73,771,722 |
Weighted Average Number of Common Shares Outstanding - Diluted | 71,297,272 | 73,771,722 |
Consolidated Statements Of Comp
Consolidated Statements Of Comprehensive Loss - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Income Statement [Abstract] | ||
Net Loss | $ (2,305,073) | $ (7,626,599) |
Foreign Currency Translation Loss | (42,802) | 22,704 |
Comprehensive Loss | $ (2,347,875) | $ (7,603,895) |
Consolidated Statements Of Stoc
Consolidated Statements Of Stockholders’ (Deficit) Equity - USD ($) | Series A Preferred Stock [Member] | Series B Preferred Stock [Member] | Common Stock [Member] | Additional Paid In Capital-Series A Preferred Stock [Member] | Additional Paid In Capital-Series B Preferred Stock [Member] | Additional Paid In Capital-Common Stock [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Retained Earnings (Accumulated Deficit) [Member] | Total |
Balance preferred stock, shares at Dec. 31, 2017 | 1,562,500 | ||||||||
Balance common stock, shares at Dec. 31, 2017 | 82,938,960 | ||||||||
Balance, value at Dec. 31, 2017 | $ 156 | $ 82,939 | $ 124,844 | $ 229,744 | $ 277,467 | $ 715,150 | |||
Issuance of 10% Convertible Promissory Notes | (50,000) | (50,000) | |||||||
Series A Preferred Stock Dividend | (2,500) | (2,500) | |||||||
Stock Option Expense | 22,857 | 22,857 | |||||||
Acquisition of Common Stock for Common Stock of Subsidiaries, shares | (13,668,900) | ||||||||
Acquisition of Common Stock for Common Stock of Subsidiaries, value | $ (13,669) | (202,601) | (660,170) | (876,440) | |||||
Issuance of Series B Convertible Preferred Stock, shares | 10,000 | ||||||||
Issuance of Series B Convertible Preferred Stock, value | $ 10 | 7,156,204 | 7,156,214 | ||||||
Conversion into Common Stock of the 10% Convertible Promissory Notes with Accrued Interest | 52,534 | 52,534 | |||||||
Issuance of 10% Convertible Promissory Notes Conversion, Shares | 38,886 | ||||||||
Issuance of 10% Convertible Promissory Notes Conversion, value | $ 39 | (39) | |||||||
Fair Value of Warrants Issued with 8% Senior Secured Convertible Promissory Note | 171,121 | 171,121 | |||||||
Fair Value of Beneficial Conversion Feature of the 8% Senior Secured Convertible Promissory Note | 523,326 | 523,326 | |||||||
Inducement Shares Issued for the 8% Senior Secured Convertible Promissory Note | 89,531 | 89,531 | |||||||
Common Stock issued as Financing Fee for the Equity Purchase Agreement, value | |||||||||
Foreign Currency Translation Gain/(Loss) | 22,704 | 22,704 | |||||||
Net Loss | (7,626,599) | $ (7,626,599) | |||||||
Balance preferred stock , shares at Dec. 31, 2018 | 1,562,500 | 10,000 | |||||||
Balance common stock, shares at Dec. 31, 2018 | 69,308,946 | 69,308,946 | |||||||
Balance, value at Dec. 31, 2018 | $ 156 | $ 10 | $ 69,309 | 124,844 | 7,156,204 | 836,473 | 22,704 | (8,011,802) | $ 197,898 |
Conversion into Common Stock of the 10% Convertible Promissory Notes with Accrued Interest | |||||||||
Issuance of Inducement common shares, shares | 156,250 | ||||||||
Issuance of Inducement common shares, value | $ 156 | (156) | |||||||
Partial Conversion of 8% Senior Secured Convertible Promissory Notes, shares | 3,436,526 | ||||||||
Partial Conversion of 8% Senior Secured Convertible Promissory Notes, value | $ 3,437 | 653,810 | 657,247 | ||||||
Fair Value of Warrants Issued with 8% Senior Secured Convertible Promissory Note - 2nd Tranche | 121,320 | 121,320 | |||||||
Fair Value of Beneficial Conversion Feature of the 8% Senior Secured Convertible Promissory Note - 2nd Tranche | 403,689 | 403,689 | |||||||
Fair Value of Beneficial Conversion Feature of the 8% Senior Secured Convertible Promissory Note – 12/2/2019 Note | 132,500 | 132,500 | |||||||
Common Stock issued as Financing Fee for the Equity Purchase Agreement, shares | 300,000 | ||||||||
Common Stock issued as Financing Fee for the Equity Purchase Agreement, value | $ 300 | 48,000 | (48,300) | ||||||
Foreign Currency Translation Gain/(Loss) | (42,802) | (42,802) | |||||||
Net Loss | (2,305,073) | $ (2,305,073) | |||||||
Balance preferred stock , shares at Dec. 31, 2019 | 1,562,500 | 10,000 | |||||||
Balance common stock, shares at Dec. 31, 2019 | 73,201,722 | 73,201,722 | |||||||
Balance, value at Dec. 31, 2019 | $ 156 | $ 10 | $ 73,202 | $ 124,844 | $ 7,156,204 | $ 2,195,636 | $ (20,098) | $ (10,316,875) | $ (786,921) |
Consolidated Statements Of St_2
Consolidated Statements Of Stockholders’ (Deficit) Equity (Parenthetical) | 12 Months Ended |
Dec. 31, 2019 | |
Statement of Stockholders' Equity [Abstract] | |
Note Date | Dec. 2, 2019 |
Consolidated Statements Of Cash
Consolidated Statements Of Cash Flow - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Cash Flow from Operating Activities: | ||
Net Loss | $ (2,305,073) | $ (7,626,599) |
Adjustments to Reconcile Net (Loss) to Net Cash Used In Operating Activities: | ||
Impairment Expense | 6,285,214 | |
Amortization of Note Discounts | 1,191,894 | 295,398 |
Changes in Operating Assets and Liabilities: | ||
Other Receivables | 27,860 | 32,657 |
Prepaids | (18,567) | 19,190 |
Deposits | 274 | (14,199) |
Accounts Payable and Accrued Liabilities | 171,652 | 96,452 |
Discontinued Operations, net | (358,355) | |
Net Cash Used In Operating Activities | (950,546) | (1,373,936) |
Cash Flow from Financing Activities: | ||
Preferred Stock Dividend | 2,500 | |
Promissory Note from MAAB | 158,578 | 591,439 |
8% Senior Secured Convertible Promissory Note | 600,000 | 600,000 |
8% Senior Secured Convertible Promissory Note, Issued December 2, 2019 | 125,000 | |
Issuance of Common Stock for Financing Fee | (48,300) | |
Non-cash Financing Fee | 7,500 | |
Net Cash Provided By Financing Activities | 939,378 | 1,188,939 |
Effect of Foreign Currency Translation (Loss) Gain | (42,802) | 22,704 |
Net Decrease in Cash | (53,970) | (162,293) |
Cash at the Beginning of the Year | 55,129 | 217,422 |
Cash at the End of the Year | 1,159 | 55,129 |
Supplemental Disclosures of Cash Flow Information: | ||
Cash Paid During the Period for: Interest | 4,598 | 9,232 |
Cash Paid During the Period for: Taxes | 24,930 | |
Supplemental Disclosures of Non-Cash Information: | ||
10% Convertible Promissory Notes Issued in Exchange for Stock Options | 50,000 | |
Common Stock Received in Sale of Discontinued Operations | 876,440 | |
Assets Sold in Discontinued Operations for Common Stock | 1,941,259 | |
Liabilities Sold in Discontinued Operations for Common Stock | (1,064,818) | |
Series B Preferred Stock Issued in Acquisition of Assets | 7,156,214 | |
Acquired In-Process Research and Development | 7,181,214 | |
Accounts Payable and Accrued Liabilities Assumed in Acquisition of Assets | 25,000 | |
Conversion into Common Stock of the 10% Convertible Promissory Notes with Accrued Interest | 52,534 | |
Conversion of 8% Senior Secured Convertible Promissory Notes into Common Stock | 657,247 | |
Discounts Issued with 8% Senior Secured Convertible Promissory Notes | 606,827 | 101,818 |
Discounts Issued with 8% Senior Secured Convertible Promissory Note, Issued December 2, 2019 | 149,546 | |
Discounts Issued in Connection with Forbearance Agreement for 8% Senior Secured Convertible Promissory Notes | 257,135 | |
Amortization to Interest Expense of the Debt Discount from the 8% Senior Secured Convertible Promissory Note | 1,167,801 | 108,886 |
Amortization to Interest Expense of the Debt Discount from the 8% Senior Secured Convertible Promissory Note, Issued December 2, 2019 | 24,093 | |
Allocation to Interest Expense from Debt Discount of the 8% Senior Secured Convertible Promissory Note | 163,978 | |
Common Stock issued as Financing Fee for the Equity Purchase Agreement | (48,300) | |
Reduction in MAAB Promissory Note from Section 16(a) Short Swing Profit Income | $ 178,394 |
Consolidated Statements Of Ca_2
Consolidated Statements Of Cash Flow (Parenthetical) | 12 Months Ended |
Dec. 31, 2019 | |
Statement of Cash Flows [Abstract] | |
Note Date | Dec. 2, 2019 |
Nature Of Operations
Nature Of Operations | 12 Months Ended |
Dec. 31, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Operations | NOTE 1 – NATURE OF OPERATIONS Astro Aerospace Ltd. (“Astro” or the “Company”) and its wholly-owned subsidiaries, is a developer of self-piloted and autonomous, manned and unmanned, eVTOL (Electric Vertical Take Off and Landing) aerial vehicles. The Company intends to provide the market with a mainstream mode of everyday, aerial transportation for both humans and cargo. Astro currently has a working prototype and is making engineering and mechanical improvements to it. Astro is the successor corporation to CPSM, Inc., which through its subsidiaries, Custom Pool and Spa Mechanics, Inc. (“Custom Pool and Spa”), and Custom Pool Plastering, Inc. (“CPP”) collectively (“Custom Pool”) were primarily engaged in the provision of full line pool and spa services, specializing in pool maintenance and service, repairs, leak detection, renovations, decking and remodeling. The primary market area included Martin, Palm Beach, St Lucie, Indian River and Brevard counties, Florida. On March 14, 2018, MAAB Global Limited (“MAAB”), the majority stockholder and parent of Astro, acquired control of CPSM, Inc. and on April 30, 2018, Custom Pool was sold to the Lawrence & Loreen Calarco Family Trust, an entity controlled by Lawrence Calarco and Loreen Calarco, former officers and directors of the CPSM (See Note 2, “Sale of Common Stock of Majority Stockholders and Resignation and Election of the Board of Directors” and Note 3, “ Sale of Custom Pool”). On March 24, 2018 the articles of incorporation were amended to change the name of the Company from CPSM, Inc. to Astro Aerospace Ltd. As of December 31, 2019, the Company has one subsidiary, Astro Aerospace Ltd. (Canada), which is incorporated in Canada and is used mainly for refunds of the Goods and Services Tax in Canada. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of our business. As reflected in the accompanying consolidated financial statements, for the year ended December 31, 2019 the Company had a net loss of $2,305,073 and used $950,546 in cash in operations, and at December 31, 2019, had negative working capital of $921,829, current assets of $62,299, and an accumulated deficit of $10,316,875. The foregoing factors raise substantial doubt about the Company’s ability to continue as a going concern. Ultimately, the ability to continue as a going concern is dependent upon the Company’s ability to attract significant new sources of capital, attain a reasonable threshold of operating efficiencies and achieve profitable operations by licensing or otherwise commercializing products incorporating the Company’s technologies. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company acknowledges that its current cash position is insufficient to maintain the current level of operations and research and development, and that the Company will be required to raise substantial additional capital to continue its operations and fund its future business plans. The Company has continued to raise funds through its parent, MAAB and the outstanding note payable balance was $750,017 and there is $499,983 available under the terms of the note at December 31, 2019. The note was amended on April 22, 2020 (See Note 20, “Subsequent Events”). The Company has also raised funds through independent capital sources, of which the Company has two 8% Senior Secured Convertible Promissory Notes, the first of which has an outstanding balance of $983,524 at December 31, 2019 and the second of which has an outstanding balance of $149,546 at December 31, 2019. The first 8% Senior secured Convertible Note is subject to a forbearance agreement (See Note 10, “Default and Forbearance on the 8% Senior Secured Convertible Promissory Note”). The Company has also executed an Equity Purchase Agreement whereby the Investor agreed to purchase from the Company up to $5,000,000 of the Company’s common stock. (See Note 16, “Equity Purchase Agreement and Registration Rights Agreement”). Through May 29, 2020, the Company put 1,050,000 shares of common stock at prices ranging from $.055 to $.081 per share for total proceeds of $63,664. Astro plans to raise additional capital in the private and public securities markets in 2020. |
Sale Of Common Stock Of Majorit
Sale Of Common Stock Of Majority Stockholders And Resignation And Election Of The Board Of Directors | 12 Months Ended |
Dec. 31, 2019 | |
Sale Of Common Stock Of Majority Stockholders And Resignation And Election Of Board Of Directors | |
Sale of Common Stock of Majority Stockholders and Resignation and Election of the Board of Directors | NOTE 2 – SALE OF COMMON STOCK OF MAJORITY STOCKHOLDERS AND RESIGNATION AND ELECTION OF THE BOARD OF DIRECTORS On March 14, 2018, Lawrence and Loreen Calarco, officers and directors of the Company, the Lawrence & Loreen Calarco Family Trust and the Lawrence and Loreen Calarco Trust of June 3, 2014, majority stockholders controlled by Lawrence and Loreen Calarco, sold 51,711,571 common shares and 1,562,500 preferred shares to MAAB, a non-affiliate of the Company, paid from Bruce Bent, officer and director of MAAB’s personal funds resulting in a change of control of the Company. The stock was transferred to MAAB effective March 14, 2018. The 51,711,571 common shares and 1,562,500 preferred shares represented 62.35% and 100% of the issued and outstanding common and preferred stock of the Company, respectively. On March 14, 2018, Lawrence Calarco, Loreen Calarco and Charles Dargan II resigned as officers and directors of the Company. Additionally, on March 14, 2018, Jeffrey Michel and Randy Sofferman resigned as directors of the Company. On March 14, 2018, Bruce Bent, age 62, was appointed as Chief Executive Officer and Director of the Company. He stood for re-election at the subsequent annual meeting of the shareholders. There are no material arrangements to which Mr. Bent is a party, and there is no family relationship between him and any other party connected to the Company. |
Sale Of Custom Pool
Sale Of Custom Pool | 12 Months Ended |
Dec. 31, 2019 | |
Notes to Financial Statements | |
Sale Of Custom Pool | NOTE 3 – SALE OF CUSTOM POOL On April 30, 2018, pursuant to a Share Exchange Agreement dated April 16, 2018, the Company sold all of the issued and outstanding common shares of Custom Pool & Spa Mechanics, Inc. and Custom Pool Plastering, its wholly owned subsidiaries, for 13,668,900 common shares of the Company held by the Lawrence & Loreen Calarco Family Trust, an entity controlled by Lawrence Calarco and Loreen Calarco, former officers and directors of the Company. The Board of Directors subsequently authorized the cancellation of those common shares. After said cancellation, the total issued and outstanding common shares was 69,270,060. The Share Exchange Agreement was approved by the Board of Directors and written consent of shareholders holding 62.35% of the voting securities of the Company as of April 16, 2018. The Company determined that there would be no gain or loss on the sale in accordance with Accounting Standards Codification 505-30-10, “Equity – Nonreciprocal Transfers with Owners”. Essentially the transaction is similar to a spin-off or reorganization since the Company acquired shares of its own common stock for the common shares of Custom Pool & Spa Mechanics, Inc. and Custom Pool Plastering, its wholly owned subsidiaries. As such, the transaction is accounted for at the recorded (book value) amount. The book value of the net assets was $876,440. Custom Pool is presented as a discontinued operation in the consolidated financial statements. The following is a reconciliation of the major line items constituting income of discontinued operations, net that are presented in the accompanying Consolidated Statements of Operations: Years Ended December 31, 2019 2018 Major Classes of Line Items Constituting Pre-Tax Income on Discontinued Operations: Revenue $ — $ 1,786,911 Cost of Services — 1,208,619 General and Administrative — 338,877 Other Operating Expenses — 51,370 Total Operating Expenses — 1,598,866 Operating Income — 188,045 Other Expense — 9,745 Total Pre-Tax Income from Discontinued Operations — 178,300 Income Tax Expense — (37,367 ) Income from Discontinued Operations $ — $ 140,933 |
Acqusition Of Assets From Confi
Acqusition Of Assets From Confida Aerospace Ltd | 12 Months Ended |
Dec. 31, 2019 | |
Business Combinations [Abstract] | |
Acquisition of Assets from Confida Aerospace, Ltd | NOTE 4 – ACQUSITION OF ASSETS FROM CONFIDA AEROSPACE, LTD. On May 8, 2018, the Company entered into an Asset Purchase Agreement with Confida Aerospace Ltd. Pursuant to the Asset Purchase Agreement, the Company purchased in-process research and development (“IPRD”) consisting of inventory, hardware designs, software designs, and a trademark all pertaining to passenger drone design and use from Confida Aerospace Ltd. As consideration for the Asset Purchase Agreement, the Company issued Confida Aerospace Ltd., 10,000 of the Company’s Series B preferred shares (See, Note 13, “Convertible Preferred Stock”). Each preferred share is convertible into 1,333 common shares and 1,333 warrants. Each warrant is exercisable into one of the Company’s common shares at an exercise price of $.75. The warrants have an exercise period of five years upon conversion. Additionally, the Company assumed $50,000 of debts incurred by Confida Aerospace Ltd. related to drone development. All of the authorized shares of the Series B Convertible Stock were issued for the assets and $50,000 of accrued liabilities were assumed. The fair market value of the preferred stock was $7,131,214 as determined by an independent third party valuation firm. The fair market value was arrived at using an equivalent conversion into the common stock of Astro, which is trading in the Over-The-Counter Market. Appropriate restrictions and marketability discounts were applied, including using the 40 day volume weighted average price of $0.46 per share. The fair value of the common stock equivalent was $3,753,271. As well, the warrants issued in conjunction with the common stock were valued using the Black Scholes Model. The inputs used were a 40 day volume weighted average price of $0.46 per share, exercise price of $0.75 per share, a ten year term, a risk free rate of 2.97%, a volatility of 51% and no dividend yield. The fair value of the warrants was $3,377,943. The Company determined the fair value of the IPRD based on the fair market value of the consideration paid for the IPRD: 10,000 shares of Series B Convertible Preferred Stock, each share of which is convertible into 1,333 shares of common stock and 1,333 common stock warrants. The drone prototype is in an early development stage and the fair value is not determinable using cash flow projections and such projections were not available. It is anticipated that the drone will be marketable and flying by the end of the second quarter of 2021 and at that time that cash flows are expected to commence. Further analysis of the IPRD determined that the recoverability of the fair value carrying amount was not probable and an impairment expense of $6,310,214 was incurred to reduce the carrying value of the net assets to $871,000, which approximates cost. As well, after the initial 90 day period for the assumption of liabilities, the Company determined that it would most likely only assume $25,000 of liabilities and has adjusted the consolidated financial statements accordingly. During 2018, the expenses related to the liabilities had been incurred and the impairment expense was reduced by $25,000 to $6,285,214. |
Summary Of Significant Accounti
Summary Of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2019 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | NOTE 5 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated. Basis of Presentation The accompanying consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles general accepted in the United States of America (“GAAP). Cash All highly liquid investments with original maturities of three months or less or money market accounts held at financial institutions are considered to be cash. Substantially all of the cash is placed with one financial institution. From time to time during the year the cash accounts are exposed to credit loss for amounts in excess of insured limits of $250,000 in the event of non-performance by the institution, however, it is not anticipated that there will be non-performance. Intangible Assets – Acquired In-Process Research and Development Acquired in-process research and development consists of acquired drone technology and engineering and trademarks. The Company reviews the IPRD, which currently has an indefinite useful life, for impairment at least annually or more frequently if an event occurs creating the potential for impairment, until such time as the research and development efforts are completed or abandoned. If the research and development efforts are abandoned, the related costs will be written off in the period of such determination. If the research and development efforts are completed successfully, the related assets will be amortized over the estimated useful life of the underlying products. The Company will amortize the cost of identified intangible assets using amortization methods that reflect the pattern in which the economic benefits of the intangible assets are consumed or otherwise realized. An impairment expense of $6,285,214 was incurred in the year ended December 31, 2018. An updated valuation by an independent third party was performed for the year ended December 31, 2019, and no further impairment expense was required. Revenue Recognition The Company does not currently have any revenue. In discontinued operations, revenue was recognized when the pool service was completed and the collectability was reasonably assured. For pool resurfacing and remediation work, revenue was recognized at the time of completion of the job. Stock-Based Compensation The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors including stock options and restricted stock issuances based on estimated fair values. In accordance with GAAP, the fair value of stock-based awards is generally recognized as compensation expense over the requisite service period, which is defined as the period during which an employee is required to provide service in exchange for an award. The Company uses a straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in operations. Convertible Notes, Warrants and Beneficial Conversion Feature (“BCF”) The convertible note is recorded at its fair value, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the warrant. Further, the convertible promissory note is examined for any intrinsic BCF of which the convertible price of the note is less than the closing common stock price on date of issuance. If the relative fair value method is used to value the convertible promissory note and there is an intrinsic BCF, a further analysis is undertaken of the BCF using an effective conversion price which assumes the conversion price is the relative fair value divided by the number of shares the convertible debt is converted into by its terms. The BCF value is accounted for as equity. Warrants issued with the 8% Senior Secured Convertible Promissory Note are accounted for under the fair value and relative fair value method. The warrant is first analyzed per its terms as to whether it has derivative features or not. If the warrant is determined to be a derivative and not qualify for equity treatment, then it is measured at fair value using the Black Scholes option model and recorded as a liability on the consolidated balance sheet. The warrant is re-measured at its then current fair value at each subsequent reporting date (it is “marked-to-market”). If the warrant is determined to not have derivative features, it is recorded into equity at its fair value using the Black Scholes option model, however, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the convertible note. The warrant and BCF relative fair values are also recorded as a discount to the convertible promissory notes and as additional paid-in-capital. The discount on the convertible notes is amortized to interest expense over the life of the debt. At present, these equity features of the convertible promissory notes have recorded a discount to the convertible notes that is substantially equal to the proceeds received. Research and Development Research and development costs are expensed as incurred. Income Taxes The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of asset and liabilities. Deferred tax assets and liabilities are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The effect on deferred tax asset and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The Company accounts for uncertainties in income tax law under a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns as prescribed by GAAP. Under GAAP, the tax effects of a position are recognized only if it is “more-likely-than-not” to be sustained by the taxing authority as of the reporting date. If the tax position is not considered “more-likely-than-not” to be sustained, then no benefits of the position are recognized. Management believes there are no unrecognized tax benefits or uncertain tax positions as of December 31, 2019 and 2018. The Company assessed its earnings history, trends and estimates of future earnings and determined that the deferred tax asset could not be realized as of December 31, 2019. Accordingly, a valuation allowance was recorded against the net deferred tax asset. The Company recognizes interest and penalties on income taxes as a component of income tax expense, should such an expense be realized. Basic and Diluted Net Loss per Share The Company computes loss per share in accordance with “ASC-260”, “Earnings per Share” which requires presentation of both basic and diluted loss per share on the face of the consolidated statements of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the year. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the year, computed using the treasury stock method for outstanding stock options and the if converted method for convertible notes and preferred stock. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. Common stock equivalents are anti-dilutive for the years ended December 31, 2019 and 2018 due to the net loss during the years. The common stock equivalents are comprised of stock options (cancelled as of March 14, 2018), convertible promissory notes and the Series A and Series B Convertible Preferred Stock. Further, the Company has presented its discontinued operations in accordance with ASC 205-20, “Presentation of Financial Statements, Discontinued Operations”, which requires the presentation of both basic and diluted loss per share from continuing operations and the basic and diluted net earnings per share from discontinued operations in addition to the basic and diluted net loss per share. For the years ended December 31, 2019 and 2018, the basic and diluted net loss per share from continuing operations, the basic and diluted net earnings from discontinued operations and the basic and diluted net loss per share were computed as follows: Year Ended December 31, 2019 2018 Loss from Continuing Operations, net $ (2,305,073 ) $ (7,767,532 ) Income from Discontinued Operations, net — 140,933 Net Loss Available to Common Stockholders (2,305,073 ) (7,626,599 ) Series A Preferred Stock Dividends 10,000 10,000 Net Loss Available to Common Stockholders and Assumed Conversions $ (2,315,073 ) $ (7,636,599 ) Weighted Average Shares - Basic 71,297,272 73,771,722 Effective Dilutive Securities – Stock Options — — Shares Issuable Upon Conversion of Convertible Promissory Notes — — Shares Issuable Upon Conversion of Preferred Stock – Series A — — Shares Issuable Upon Conversion of Preferred Stock – Series B — — Weighted Average Shares - Diluted 71,297,272 73,771,722 Net Loss Per Common Share from Continuing Operations: Basic $ (0.03 ) $ (0.11 ) Diluted $ (0.03 ) $ (0.11 ) Net Earnings Per Common Share from Discontinued Operations: Basic $ — $ — Diluted $ — $ — Net Loss Per Common Share: Basic $ (0.03 ) $ (0.10 ) Diluted $ (0.03 ) $ (0.10 ) Comprehensive Loss Comprehensive loss consists of net loss plus the foreign currency translation (loss) gain. Foreign Currency Translation The translation of assets and liabilities for the Company’s foreign subsidiary is made at year end exchange rates, while revenue and expense accounts are translated at the average exchange rates during the year transactions occurred. Fair Value Measurement Generally accepted accounting principles establishes a hierarchy to prioritize the inputs of valuation techniques used to measure fair value. The hierarchy gives the highest ranking to the fair values determined by using unadjusted quoted prices in active markets for identical assets (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). Observable inputs are those that market participants would use in pricing the assets based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about inputs market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The Company has determined the appropriate level of the hierarchy and applied it to its financial assets and liabilities. At December 31, 2019 and 2018, there were no assets or liabilities carried or measured at fair value. Use of Estimates and Assumptions The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. A material estimate that is particularly susceptible to significant change in the near-term relate to the determination of the impairment of IPRD. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make this estimate. Although considerable variability is likely to be inherent in this estimate, management believes that the amount provided is reasonable. This estimate is continually reviewed and adjusted if necessary. Such adjustments, if any, are reflected in operations. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 12 Months Ended |
Dec. 31, 2019 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | NOTE 6 – RECENT ACCOUNTING PRONOUNCEMENTS In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-2, Leases (Topic 842) which will require lessees to recognize on the consolidated balance sheet the assets and liabilities for the rights and obligations created by those leases with term of more than twelve months. Consistent with current GAAP, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification as a finance or operating lease. The new ASU will require both types of leases to be recognized on the consolidated balance sheet. The ASU also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. These disclosures include qualitative and quantitative requirements, providing additional information about the amounts recorded in the consolidated financial statements. The ASU became effective for fiscal years beginning after December 15, 2018 and for interim periods within those fiscal years. The ASU had no effect on the Company’s consolidated financial statements. In June 2018, the FASB issued ASU No. 2018-07, “Compensation – Stock Compensation (Topic 718) – Improvements to Nonemployee Share-Based Payment Accounting,” to include share based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The amendments also clarify that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Topic 606, Revenue from Contracts with Customers. The amendments in this update become effective for annual periods and interim periods within those annual periods beginning after December 15, 2018 but no earlier than an entity’s adoption date of Topic 606. The Company evaluated the impact of adopting the new guidance on the consolidated financial statements, but it does not have a material impact. |
Concentrations Of Credit Risk
Concentrations Of Credit Risk | 12 Months Ended |
Dec. 31, 2019 | |
Risks and Uncertainties [Abstract] | |
Concentrations of Credit Risk | NOTE 7 CONCENTRATIONS OF CREDIT RISK Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash. The Company maintains its cash with high-credit quality financial institutions. At December 31, 2019 and 2018 the Company did not have any cash balances in excess of federally insured limits. |
Fair Value Estimates
Fair Value Estimates | 12 Months Ended |
Dec. 31, 2019 | |
Fair Value Disclosures [Abstract] | |
Fair Value Estimates | NOTE 8 – FAIR VALUE ESTIMATES The Company measures financial instruments at fair value in accordance with ASC 820, which specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. Management believes the carrying amounts of the Company's cash, other receivables, accounts payable and accrued liabilities as of December 31, 2019 and 2018 approximate their respective fair values because of the short-term nature of these instruments. The Company measures its notes payable and loans in accordance with the hierarchy of fair value based on whether the inputs to those valuation techniques are observable or unobservable. The hierarchy is: Level 1 – Quoted prices for identical instruments in active markets; Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The estimated fair value of the cash, notes payable, and loans at December 31, 2019 and 2018, were as follows: Quoted Prices In Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Carrying Value At December 31, 2019: Assets Cash $ 1,159 — — $ 1,159 Liabilities — — 8% Senior Secured Convertible Promissory Note, Net — — $ 694,431 $ 694,431 8% Senior Secured Convertible Promissory Note issued December 2, 2019, Net — — $ 24,093 $ 24,093 Loan from MAAB — — $ 750,017 $ 750,017 At December 31, 2018: Assets Cash $ 55,129 — — $ 55,129 Liabilities 8% Senior Secured Convertible Promissory Note, Net — — $ 108,886 $ 108,886 Loan from MAAB — — $ 591,439 $ 591,439 |
8% Senior Secured Convertible P
8% Senior Secured Convertible Promissory Notes | 12 Months Ended |
Dec. 31, 2019 | |
Debt Disclosure [Abstract] | |
8% Senior Secured Convertible Promissory Notes | NOTE 9 – 8% SENIOR SECURED CONVERTIBLE PROMISSORY NOTES On November 21, 2018, the Company issued an 8% Senior Secured Convertible Promissory Note in the aggregate principal amount of $1,383,636 in exchange for a total investment of $1,200,000, less commissions and expenses, payable in two tranches. The first tranche was payable upon the closing of the agreement, and the second tranche was payable within ten (10) business days of the Investor receiving written notice confirming the effectiveness of the initial registration statement. The first tranche principal of $701,818 was issued, with an Original Issue Discount (“OID”) of $81,818, a $20,000 financing fee for the lender’s transactional expenses that was expensed and the Company received proceeds of $600,000. The second tranche was issued on February 12, 2019 in the principal amount of $681,818, with an OID of $81,818 and the Company received proceeds of $600,000. Each tranche matured 6 months after the issue date, the first tranche matured on May 21, 2019 and the second tranche matured on August 12, 2019 (See Note 10, “Default And Forbearance On The 8% Senior Secured Convertible Promissory Note”). The Note is convertible into common shares of the Company at a price equal to 75% of the lowest market value in the thirty trading days prior to the conversion date. The Company is subject to certain penalties if the shares are not issued within two business days of receiving the conversion notice. Pursuant to a Security Agreement between the Company and the Investor (the “Security Agreement”), the Company has granted to the Investor a security interest in its assets to secure repayment of the Notes. The Company must reserve an amount of shares equal to 500% of the total amount of shares issuable upon full conversion of the promissory note. The Company meets this requirement since it has 250,000,000 common shares authorized and as of May 29, 2020, 88,882,955 shares available to be issued. As additional consideration for the investment, the Company issued 156,250 shares of its common stock to the Investor, valued at $89,531 at the date of issuance, plus warrants to acquire up to an aggregate 344,029 shares of the Company’s common stock at an exercise price of $0.51 per share. Upon the closing of the second tranche in February 2019, the Company issued additional warrants to acquire up to an aggregate amount of 421,656 shares of the Company’s common stock at an exercise price of $0.40 per share. Each Warrant is exercisable by the Investor beginning on the Effective Date through the fifth year anniversary thereof. The Note has a beneficial conversion feature (“BCF”) for both tranches, which were valued, along with the warrants, on a relative fair value method. In the first tranche, the warrant fair value (See Note 15, “Warrants”) was $171,121 and the beneficial conversion feature fair value was $523,326 for a total debt discount of $694,447. The conversion price was $0.375 per share which converts into 1,871,515 common shares. The common stock price at the valuation date was $0.57 per share, so that the BCF was calculated to be $0.28 per share valuing the BCF at $523,326. However, adding the OID and the inducement shares to the debt discount, made final total debt discount $865,796, larger than the principal amount of the Note. Consequently, $163,978 of the debt discount was expensed. Additionally, $108,886 of the debt discount was amortized to interest expense for the year ended December 31, 2018, with an additional $534,682 amortized to interest in the year ended December 31, 2019, bringing the debt discount to $58,250 at December 31, 2019. In the second tranche, the warrant fair value (See Note 15, “Warrants”) was $121,320 and the beneficial conversion feature fair value was $403,689 for a debt discount of $525,009. Including the $81,818 of OID, the total debt discount is $606,827. Prior to the forbearance agreement dated September 11, 2019, $498,402 of the debt discount was amortized into interest expense, bringing the debt discount to $108,425. However, the forbearance agreement increased the principal amount, and the debt discount, which were allocated to the second tranche, so there was a net increase in the principal and the debt discount in the second tranche of $257,135 (See Note 10, “Default and Forbearance on the 8% Senior Secured Convertible Promissory Note”). Additional amortization of the debt discount into interest expense in the fourth quarter of the year ended December 31, 2019 was $117,986 bringing the debt discount to $230,843 at December 31, 2019. On February 22, 2019, the Investor converted $55,387 in principal amount of the Note into 215,054 shares of the Company’s common stock. Likewise, on March 19, 2019, the Investor converted $38,633 in principal amount of the Note into 150,000 shares of the Company’s common stock. However, the conversion share calculation was incorrect for the March 19, 2019 conversion of the $38,633 in principal amount of the Note and was 26,712 shares less than what it should have been. These shares were added to a subsequent conversion in April 2019. In the second quarter ended June 30, 2019, the Investor converted $449,397 in principal amount of the Note into 1,830,373 shares of the Company’s common stock. In the third quarter ended September 30, 2019, the Investor converted $93,830 in principal amount of the Note into 750,000 shares of the Company’s common stock. In the fourth quarter ended December 31, 2019, the Investor converted $20,000 in principal amount of the Note into 491,099 shares of the Company’s common stock. The Company has accrued interest on the Note of $83,557 through December 31, 2019. The effective interest rate for both tranches of this Note was 8.33% as of December 31, 2019 and 2018. On December 2, 2019, the Company issued a new 8% Senior Secured Convertible Promissory Note in the aggregate principal amount of up to $575,682. The initial tranche principal of $149,546 was issued, with an OID of $17,046, the pro-rated portion of the $68,182 OID for the entire principal amount of $575,682, a $7,500 financing fee for the lender’s transactional expenses that was expensed and the Company received proceeds of $125,000. The Note will mature on June 2, 2020. The Note is convertible into common shares of the Company at a price equal to 75% of the lowest market value in the thirty trading days prior to the conversion date, which created a BCF valued at greater than the total principal amount of the Note issued of $149,546. The conversion price was $0.0375 per share which converts into 3,987,880 common shares. The common stock price at the valuation date was $0.13 per share, so that the BCF was calculated to be $0.0925 per share valuing the BCF at $368,879. In accordance with ASC 470-20-30-8, if the intrinsic value of the BCF is greater than the proceeds allocated to the convertible instrument, the amount of the discount assigned to the BCF shall be limited to the amount of the proceeds allocated to the convertible instrument. Therefore, the BCF is limited to $132,500, which when added to the OID of $17,046 equals the principal amount of $149,546. The BCF is being amortized using the effective interest method over the term of the note. Amortization of the debt discount into interest expense was $24,093 for the year ended December 31, 2019, bringing the debt discount to $125,453 at December 31, 2019. The Company has accrued interest of $1,927 on the Note through the year ended December 31, 2019. The effective interest rate for this Note was 8.33% at December 31, 2019. |
Default And Forbearance On The
Default And Forbearance On The 8% Senior Secured Convertible Promissory Note | 12 Months Ended |
Dec. 31, 2019 | |
Debt Disclosure [Abstract] | |
Default and Forbearance on the 8% Senior Secured Convertible Promissory Note | NOTE 10 – DEFAULT AND FORBEARANCE ON THE 8% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE On May 21, 2019, six months after the issuance of the first tranche of the 8% Senior Secured Convertible Promissory Note, the Note matured with $307,798 in principal outstanding and approximately $24,118 in accrued interest. The Company was unable to repay the principal and accrued interest and therefore was in default of the Note. The Note has default provisions permitting default interest of 18% to be charged on the Note as well as to charge a default amount of 150% of the unpaid principal and interest. The Note was issued with two $600,000 tranches of cash payments. Since both tranches are in one Note, both tranches are in default as of May 21, 2019. The Company and the Investor promptly began negotiations on a Forbearance Agreement and on September 11, 2019, the Company and the Investor agreed to a Forbearance Agreement. Pursuant to this agreement, the Investor is willing to postpone pursuing its rights and remedies under the agreements, in particular and without limitation with respect to the acceleration of the promissory note and the immediate payment of the default amount and reduce the balance of the promissory note to the pre-default balance plus accrued non-default interest of $1,062,784 on the following terms: 1) Subject to the Company’s compliance with the forbearance agreement, the forbearance shall commence on the effective date and will expire on June 30, 2020. 2) Should the Company fail to abide by any of the terms and conditions of the forbearance agreement, fail to comply with the terms of the other agreements, or fail to timely make the payments required under the promissory notes, or should the Company trigger an event of default, the forbearance period will immediately terminate. 3) Subject to the Company’s compliance with the forbearance period, the repayment of the promissory note will be reduced from 35% to 0%. The Company’s outstanding principal amount of the Note, after conversions, and the accrued interest as of the Forbearance Agreement date of September 11, 2019, was $805,649. The Forbearance Agreement for the outstanding principal amount and accrued interest of $1,062,784 produces a forbearance penalty of $257,135. This amount increased both the principal balance of the Note and increased the debt discount by the same amount. The $257,135 penalty is being amortized over the new maturity of the Note, June 30, 2020, and resulted in a $97,747 amortization expense during the year ended December 31, 2019. The outstanding principal amount of the Note is $983,524 at December 31, 2019. |
Convertible Promissory Notes
Convertible Promissory Notes | 12 Months Ended |
Dec. 31, 2019 | |
Debt Disclosure [Abstract] | |
Convertible Promissory Notes | NOTE 11 – CONVERTIBLE PROMISSORY NOTES On March 14, 2018, 1,500,000 stock options were cancelled and two 10% Convertible Promissory Notes (“Notes”) with a six month maturity were issued to the former option holders. The principal amount was $25,000 each and there was no prepayment penalty. The Notes were convertible into the Company’s common stock based upon the average of the previous ten trading days’ closing price of the stock, at the maturity date of the Notes. Upon conversion of the notes, Bruce Bent or MAAB had the option to purchase the common stock issued at a 5% discount to the average closing price of the stock over the previous 10 trading days. The option to purchase was set to expire ten days after the issuance of the common stock. The option was not exercised. On September 18, 2018, at the maturity of the Notes, the entire outstanding balance was converted into 38,886 shares of common stock of the Company, which included $2,534 of accrued interest. The Company issued the shares of common stock on October 22, 2018. |
Promissory Note From MAAB
Promissory Note From MAAB | 12 Months Ended |
Dec. 31, 2019 | |
Debt Disclosure [Abstract] | |
Promissory Note From MAAB | NOTE 12 – PROMISSORY NOTE FROM MAAB On March 14, 2018, MAAB, the parent of Astro, issued a Promissory Note for monetary advances to the Company of up to $750,000. The Promissory Note matures on February 28, 2021. The Promissory Note has an interest charge of 10%, compounded monthly. Interest accrues on the principal amount or portion thereof which remains unpaid from time to time as well as any interest outstanding, from the date the principal amount is advanced until and including the date upon which the principal amount and all interest due under this promissory note shall be fully paid. The principal amount advanced under the Promissory Note was $591,439 through December 31, 2018 and $750,017 through December 31, 2019. The Company has accrued interest expense of $41,291 and $89,797 at December 31, 2018 and 2019, respectively. On April 22, 2020, the Promissory Note was amended to increase the principal amount and the maturity date. (See Note 20, “Subsequent Events”). |
Income Tax
Income Tax | 12 Months Ended |
Dec. 31, 2019 | |
Income Tax Narrative | |
Income tax | NOTE 13 – INCOME TAX A reconciliation of differences between the effective income tax rates and the statutory federal rates from continuing operations is as follows: 2019 2018 Rate Amount Rate Amount Income Tax benefit at US statutory Rate 21 % $ 484,065 21 % $ 1,631,172 State taxes, net of federal benefit 5 % 114,471 3 % 263,914 Change in valuation allowance (26 )% (598,546 ) (24 )% (1,895,086 ) $ — $ — The differences between the statutory Federal income tax rate and the effective tax rate are summarized as follows for the year ended December 31, 2018 for discontinued operations: Income Taxes (benefit) at Statutory Rate $ 37,443 21.0 % Increase (Decrease) in Taxes Resulting From: State Taxes, net of Federal Tax Benefit (76 ) — Graduated Tax Rates — — Reduction in Federal Income Tax Rate — — Other, Net — — Income Taxes $ 37,367 21.0 % Deferred income taxes primarily relate to differences between the amounts recorded for financial reporting purposes and the amounts recorded for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows: December 31, 2019 2018 Deferred Income Tax Assets (Liabilities): Net Operational Loss Carryforwards $ 703,548 $ 165,505 Intangible Assets 1,415,989 1,522,188 Research & Development Costs 366,868 228,699 Other, Net 7,227 (21,296 ) Gross Deferred Income Tax Assets (Liabilities) $ 2,493,632 $ 1,895,096 Less: Valuation Allowance (2,493,632 ) (1,895,096 ) Net Deferred Income Tax Asset $ — $ — At December 31, 2019, the Company has net operating loss carryforwards of approximately $2,776,000 available to offset future taxable income with no expiration. Realization of the deferred tax assets, which relate to operating loss carry-forwards and timing differences, is dependent on future earnings. The timing and amount of future earnings are uncertain and therefore the Company has established a 100% valuation allowance. As of December 31, 2019, the U.S. Federal and Florida income tax returns filed prior to 2016 are no longer subject to examination by the respective taxing authorities. |
Convertible Preferred Stock
Convertible Preferred Stock | 12 Months Ended |
Dec. 31, 2019 | |
Convertible Preferred Stock | |
Convertible Preferred Stock | NOTE 14 – CONVERTIBLE PREFERRED STOCK In December 2015, the Company authorized 50,000,000 shares of Series A Preferred Stock, with a $0.0001 par value and no liquidation value. The Series A Preferred has an 8% dividend paid quarterly and is convertible into one share of common stock. The Series A Preferred is senior to the common stock as to dividends, and any liquidation, dissolution or winding up of the Company. The Series A Preferred also has certain voting and registration rights. In January 2016, the Company issued 1,562,500 shares of the Series A Preferred Stock to Lawrence and Loreen Calarco, former officers and directors of the Company. On March 14, 2018, Lawrence and Loreen Calarco, officers and directors of the Company, the Lawrence & Loreen Calarco Family Trust and the Lawrence and Loreen Calarco Trust of June 3, 2014, sold all 1,562,500 preferred shares to MAAB, a non-affiliate of CPSM, Inc. Cumulative undeclared Series A Preferred dividends were $17,500 at December 31, 2019. On May 4, 2018, the Board of Directors of Astro Aerospace Ltd. authorized 10,000 shares of the Series B Convertible Preferred Stock, par value $0.001 per share. The Preferred is entitled to a dividend, when declared by the Board of Directors, votes with all other classes of stock as a single class of stock on all actions to be voted on by the stockholders of the Company, and each share of Preferred is convertible into 1,333 shares of common stock and a five year warrant to purchase 1,333 shares of common stock at an exercise price of $0.75 per share. On May 8, 2018, the Company issued all of the 10,000 authorized Series B Preferred shares in the acquisition of certain assets from Confida Aerospace Ltd. Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, the holders of the shares of the Series B Preferred Stock shall share pro rata with the holders of the common stock, on an as if converted basis. |
Warrants
Warrants | 12 Months Ended |
Dec. 31, 2019 | |
Notes to Financial Statements | |
Warrants | NOTE 15 – WARRANTS As part of the 8% Senior Secured Convertible Promissory Note issuance, the Company issued warrants to acquire up to an aggregate 344,029 shares of the Company’s common stock at an exercise price of $0.51 per share. These warrants were fair valued using the Black Scholes Model with the following inputs: stock price on November 21, 2018, date of issuance, $0.57, strike price $0.51, time to expiration, five years, five year Treasury constant maturity rate, 2.33%, volatility 253% and no dividend yield. The result was a fair value of $0.5676 per warrant or $195,271 in aggregate. This fair value was reduced with the relative fair value method when including the BCF of the convertible note (See Note 9, “8% Senior Secured Convertible Promissory Note”) to $171,121. The warrant relative fair value was added to additional paid in capital – common stock. In the second tranche, the Company issued warrants to acquire up to an aggregate amount of 421,656 shares of the Company’s common stock at an exercise price of $0.40 per share. These warrants were fair valued using the Black Scholes Model with the following inputs: stock price on February 12, 2019, date of issuance, $0.33, strike price $0.40, time to expiration, five years, five year Treasury constant maturity rate, 2.34%, volatility 173% and no dividend yield. The result was a fair value of $0.35 per warrant or $147,580 in aggregate. This fair value was reduced with the relative fair value method when including the BCF of the convertible note (See Note 9, “8% Senior Secured Convertible Promissory Note”) to $121,320. The warrant relative fair value was added to additional paid in capital – common stock. A summary of the warrant activity follows: Warrants outstanding Exercise price per share Price per Share on Date of Issuance Balance, December 31, 2018 13,674,029 0.51 – 0.75 0.57 – 1.00 Granted 421,656 0.40 0.33 Expired — — — Balance, December 31, 2019 14,095,685 0.40 – 0.75 0.33 – 1.00 |
Equity Purchase Agreement And R
Equity Purchase Agreement And Registration Rights Agreement | 12 Months Ended |
Dec. 31, 2019 | |
Notes to Financial Statements | |
Equity Purchase Agreement and Registration Rights Agreement | NOTE 16 - EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT On August 26, 2019, the Company entered into an Equity Purchase Agreement and Registration Rights Agreement with the same Investor who provided the funding with the 8% Senior Secured Convertible Promissory Note. Under the terms of the Equity Purchase Agreement, the Investor agreed to purchase from the Company up to $5,000,000 of the Company’s common stock upon effectiveness of a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission and subject to certain limitations and conditions set forth in the Equity Purchase Agreement. Following effectiveness of the Registration Statement, and subject to certain limitations and conditions set forth in the Equity Purchase Agreement, the Company shall have the discretion to deliver put notices to the Investor and the Investor will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to the Investor in each put notice shall not exceed the lesser of $500,000 or one hundred fifty percent (150%) of the average daily trading volume of the Company’s Common Stock during the ten (10) trading days preceding the put. Pursuant to the Equity Purchase Agreement, the Investor and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to the Investor that would result in the Investor’s beneficial ownership of the Company’s outstanding Common Stock exceeding 9.99%. The price of each put share shall be equal to eighty five percent (85%) of the Market Price (as defined in the Equity Purchase Agreement). Puts may be delivered by the Company to the Investor until the earlier of (i) the date on which the Investor has purchased an aggregate of $5,000,000 worth of Common Stock under the terms of the Equity Purchase Agreement, (ii) August 26, 2022, or (iii) written notice of termination delivered by the Company to the Investor, subject to certain equity conditions set forth in the Equity Purchase Agreement. On August 26, 2019, in connection with its entry into the Equity Purchase Agreement and the Registration Rights Agreement, the Company committed to 600,000 Commitment Shares (as defined in the Equity Purchase Agreement) to the Investor. These shares are initially being issued pursuant to the Section 4(a)(2) exemption and will be registered pursuant to the Registration Rights Agreement. Subsequent to the Agreement and prior to the issuance of the Commitment Shares, the Company renegotiated the payment to 300,000 shares of common stock. The fair value of the Commitment Shares as of August 26, 2019 was $48,300. The fair value was entirely expensed in the year ended December 31, 2019. As of December 31, 2019, the Company has not issued any stock under the Equity Purchase Agreement. The Registration Rights Agreement provides that the Company shall (i) file with the Commission the Registration Statement by November 25, 2019; and (ii) use its best efforts to have the Registration Statement declared effective by the Commission at the earliest possible date (in any event, within 120 days after the execution date of the definitive agreements). The Company filed a Registration Statement on Form S-1 with the Commission on November 25, 2019 and the S-1 was declared effective on December 27, 2019. |
2014 Stock Awards Plan
2014 Stock Awards Plan | 12 Months Ended |
Dec. 31, 2019 | |
Notes to Financial Statements | |
2014 Stock Awards Plan | NOTE 17 – 2014 STOCK AWARDS PLAN In November 2014, the board of directors of the Company approved the adoptions of a Stock Awards Plan. A total of 7,000,000 shares was authorized to be issued under the plan. For incentive stock options, at the grant date the stock options exercise price is required to be at least 110% of the fair value of the Company’s common stock. The Plan permits the grants of common stock or options to purchase common stock. As plan administrator, the Board of Directors has sole discretion to set the price of the options. Further, the Board of Directors may amend or terminate the plan. On March 14, 2018, the Company cancelled all 3,250,000 outstanding stock options under the 2014 Stock Awards Plan, with 1,500,000 of the stock options exchanged for two 10% Convertible Promissory Notes with a six month maturity (see Note 11, “Convertible Promissory Notes”). Consequently, there are 7,000,000 shares available for issuance at December 31, 2019. A summary of the stock option activity over the years ended December 31, 2019 and 2018 is as follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2017 3,250,000 $ 0.037 3.3 Years $ 56,125 Options Cancelled (3,250,000 ) — — — Outstanding at December 31, 2018 — — — — Exercisable at December 31, 2018 — — — — Outstanding at December 31, 2019 — — — — Exercisable at December 31, 2019 — — — — The Company expensed $22,857 of stock option compensation during the year ended December 31, 2018. |
Section 16(A) Beneficial Owners
Section 16(A) Beneficial Ownership Reporting Compliance | 12 Months Ended |
Dec. 31, 2019 | |
Notes to Financial Statements | |
Section 16(A) Beneficial Ownership Reporting Compliance | NOTE 18 - SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE Under Section 16(a) of the Securities Exchange Act of 1934, as amended, an officer, director, or greater-than-10% shareholder of the Company must file a Form 4 reporting the acquisition or disposition of Company’s equity securities with the Securities and Exchange Commission no later than the end of the second business day after the day the transaction occurred unless certain exceptions apply. Transactions not reported on Form 4 must be reported on Form 5 within 45 days after the end of the Company’s fiscal year. Such persons must also file initial reports of ownership on Form 3 upon becoming an officer, director, or greater-than-10% shareholder. Mr. Bruce Bent, the Company’s Chief Executive Officer, is currently up to date in meeting these requirements and has notified the Company that he is now compliant. On August 30, 2019, pursuant to Section 16(a), Mr. Bent disgorged short swing profits of $178,394 to the Company, which was recorded as miscellaneous income and a reduction of the debt owed to MAAB, the parent of the Company. |
Commitments And Contingencies
Commitments And Contingencies | 12 Months Ended |
Dec. 31, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 19 – COMMITMENTS AND CONTINGENCIES The Company does not have any significant or long term commitments. The Company is not currently subject to any litigation. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2019 | |
Subsequent Events [Abstract] | |
Subsequent Events | NOTE 20 - SUBSEQUENT EVENTS The Company has evaluated subsequent events from the consolidated balance sheet date through May 29, 2020 (the consolidated financial statement issuance date) and noted the following disclosures: The COVID-19 pandemic is currently impacting countries, communities, supply chains and markets as well as the global financial markets. Governments have imposed laws requiring social distancing, travel bans and quarantine, and these laws may limit access to the Company’s facilities, management, support staff and professional advisors. These factors, in turn, may not only impact the Company’s operations, financial condition and demand for the Company’s goods and services, but the Company’s overall ability to react timely to mitigate the impact of this event. Also, it has affected the Company’s efforts to comply with filing obligations with the Securities and Exchange Commission. Depending on the severity and longevity of the COVID-19 pandemic, the Company’s business, and stockholders may experience a significant negative impact. Currently, the COVID-19 pandemic has limited our ability to move forward with our operations and has negatively affected our ability to timely comply with our ongoing filing obligations with the Securities and Exchange Commission. On April 22, 2020, the MAAB Note Payable was amended to increase the maximum outstanding principal balance to $1,250,000 and the maturity was extended to February 28, 2022. On January 3, 2020, the Investor converted $16,724 of the principal amount of the 8% Senior Secured Convertible Promissory Note at $0.04 into 406,908 shares of the Company’s common stock. On January 29, 2020, the Investor converted $150,000 of the principal amount of the 8% Senior Secured Convertible Promissory Note at $0.053175 into 2,820,874 shares of the Company’s common stock On February 19, 2020, the Company put 400,000 common shares at a $0.0807 net price under the Equity Purchase Agreement and received $32,288 in net proceeds. On March 27, 2020, the Company put 150,000 common shares at $0.0748 under the Equity Purchase Agreement and received $9,593 in proceeds. On April 8, 2020, the Company put 150,000 common shares at $0.0685 under the Equity Purchase Agreement and received $7,527 in proceeds. On April 13, 2020, the Investor converted $10,305 of the principal amount of the 8% Senior Secured Convertible Promissory Note at $0.0515 into 200,000 shares of the Company’s common stock. On April 20, 2020, the Company put 150,000 common shares at $0.0581 under the Equity Purchase Agreement and received $5,973 in proceeds. On April 24, 2020, the Investor converted $10,305 of the principal amount of the 8% Senior Secured Convertible Promissory Note at $0.0515 into 200,000 shares of the Company’s common stock. On May 4, 2020, the Company put 200,000 common shares at $0.0551 under the Equity Purchase Agreement and received $8,283 in proceeds. On May 8, 2020, the Investor converted $11,231 of the principal amount of the 8% Senior Secured Convertible Promissory Note at $0.0449 into 250,000 shares of the Company’s common stock. |
Summary Of Significant Accoun_2
Summary Of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated. |
Basis of Presentation | Basis of Presentation The accompanying consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles general accepted in the United States of America (“GAAP). |
Cash | Cash All highly liquid investments with original maturities of three months or less or money market accounts held at financial institutions are considered to be cash. Substantially all of the cash is placed with one financial institution. From time to time during the year the cash accounts are exposed to credit loss for amounts in excess of insured limits of $250,000 in the event of non-performance by the institution, however, it is not anticipated that there will be non-performance. |
Intangible Assets – Acquired In-Process Research and Development | Intangible Assets – Acquired In-Process Research and Development Acquired in-process research and development consists of acquired drone technology and engineering and trademarks. The Company reviews the IPRD, which currently has an indefinite useful life, for impairment at least annually or more frequently if an event occurs creating the potential for impairment, until such time as the research and development efforts are completed or abandoned. If the research and development efforts are abandoned, the related costs will be written off in the period of such determination. If the research and development efforts are completed successfully, the related assets will be amortized over the estimated useful life of the underlying products. The Company will amortize the cost of identified intangible assets using amortization methods that reflect the pattern in which the economic benefits of the intangible assets are consumed or otherwise realized. An impairment expense of $6,285,214 was incurred in the year ended December 31, 2018. An updated valuation by an independent third party was performed for the year ended December 31, 2019, and no further impairment expense was required. |
Revenue Recognition | Revenue Recognition The Company does not currently have any revenue. In discontinued operations, revenue was recognized when the pool service was completed and the collectability was reasonably assured. For pool resurfacing and remediation work, revenue was recognized at the time of completion of the job. |
Stock-Based Compensation | Stock-Based Compensation The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors including stock options and restricted stock issuances based on estimated fair values. In accordance with GAAP, the fair value of stock-based awards is generally recognized as compensation expense over the requisite service period, which is defined as the period during which an employee is required to provide service in exchange for an award. The Company uses a straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in operations. |
Convertible Notes, Warrants and Beneficial Conversion Feature (“BCF”) | Convertible Notes, Warrants and Beneficial Conversion Feature (“BCF”) The convertible note is recorded at its fair value, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the warrant. Further, the convertible promissory note is examined for any intrinsic BCF of which the convertible price of the note is less than the closing common stock price on date of issuance. If the relative fair value method is used to value the convertible promissory note and there is an intrinsic BCF, a further analysis is undertaken of the BCF using an effective conversion price which assumes the conversion price is the relative fair value divided by the number of shares the convertible debt is converted into by its terms. The BCF value is accounted for as equity. Warrants issued with the 8% Senior Secured Convertible Promissory Note are accounted for under the fair value and relative fair value method. The warrant is first analyzed per its terms as to whether it has derivative features or not. If the warrant is determined to be a derivative and not qualify for equity treatment, then it is measured at fair value using the Black Scholes option model and recorded as a liability on the consolidated balance sheet. The warrant is re-measured at its then current fair value at each subsequent reporting date (it is “marked-to-market”). If the warrant is determined to not have derivative features, it is recorded into equity at its fair value using the Black Scholes option model, however, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the convertible note. The warrant and BCF relative fair values are also recorded as a discount to the convertible promissory notes and as additional paid-in-capital. The discount on the convertible notes is amortized to interest expense over the life of the debt. At present, these equity features of the convertible promissory notes have recorded a discount to the convertible notes that is substantially equal to the proceeds received. |
Research and Development | Research and Development Research and development costs are expensed as incurred. |
Income Taxes | Income Taxes The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of asset and liabilities. Deferred tax assets and liabilities are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The effect on deferred tax asset and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The Company accounts for uncertainties in income tax law under a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns as prescribed by GAAP. Under GAAP, the tax effects of a position are recognized only if it is “more-likely-than-not” to be sustained by the taxing authority as of the reporting date. If the tax position is not considered “more-likely-than-not” to be sustained, then no benefits of the position are recognized. Management believes there are no unrecognized tax benefits or uncertain tax positions as of December 31, 2019 and 2018. The Company assessed its earnings history, trends and estimates of future earnings and determined that the deferred tax asset could not be realized as of December 31, 2019. Accordingly, a valuation allowance was recorded against the net deferred tax asset. The Company recognizes interest and penalties on income taxes as a component of income tax expense, should such an expense be realized. |
Basic and Diluted Net Loss per Share | Basic and Diluted Net Loss per Share The Company computes loss per share in accordance with “ASC-260”, “Earnings per Share” which requires presentation of both basic and diluted loss per share on the face of the consolidated statements of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the year. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the year, computed using the treasury stock method for outstanding stock options and the if converted method for convertible notes and preferred stock. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. Common stock equivalents are anti-dilutive for the years ended December 31, 2019 and 2018 due to the net loss during the years. The common stock equivalents are comprised of stock options (cancelled as of March 14, 2018), convertible promissory notes and the Series A and Series B Convertible Preferred Stock. Further, the Company has presented its discontinued operations in accordance with ASC 205-20, “Presentation of Financial Statements, Discontinued Operations”, which requires the presentation of both basic and diluted loss per share from continuing operations and the basic and diluted net earnings per share from discontinued operations in addition to the basic and diluted net loss per share. For the years ended December 31, 2019 and 2018, the basic and diluted net loss per share from continuing operations, the basic and diluted net earnings from discontinued operations and the basic and diluted net loss per share were computed as follows: Year Ended December 31, 2019 2018 Loss from Continuing Operations, net $ (2,305,073 ) $ (7,767,532 ) Income from Discontinued Operations, net — 140,933 Net Loss Available to Common Stockholders (2,305,073 ) (7,626,599 ) Series A Preferred Stock Dividends 10,000 10,000 Net Loss Available to Common Stockholders and Assumed Conversions $ (2,315,073 ) $ (7,636,599 ) Weighted Average Shares - Basic 71,297,272 73,771,722 Effective Dilutive Securities – Stock Options — — Shares Issuable Upon Conversion of Convertible Promissory Notes — — Shares Issuable Upon Conversion of Preferred Stock – Series A — — Shares Issuable Upon Conversion of Preferred Stock – Series B — — Weighted Average Shares - Diluted 71,297,272 73,771,722 Net Loss Per Common Share from Continuing Operations: Basic $ (0.03 ) $ (0.11 ) Diluted $ (0.03 ) $ (0.11 ) Net Earnings Per Common Share from Discontinued Operations: Basic $ — $ — Diluted $ — $ — Net Loss Per Common Share: Basic $ (0.03 ) $ (0.10 ) Diluted $ (0.03 ) $ (0.10 ) |
Comprehensive Loss | Comprehensive Loss Comprehensive loss consists of net loss plus the foreign currency translation (loss) gain. |
Foreign Currency Translation | Foreign Currency Translation The translation of assets and liabilities for the Company’s foreign subsidiary is made at year end exchange rates, while revenue and expense accounts are translated at the average exchange rates during the year transactions occurred. |
Fair Value Measurement | Fair Value Measurement Generally accepted accounting principles establishes a hierarchy to prioritize the inputs of valuation techniques used to measure fair value. The hierarchy gives the highest ranking to the fair values determined by using unadjusted quoted prices in active markets for identical assets (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). Observable inputs are those that market participants would use in pricing the assets based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about inputs market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The Company has determined the appropriate level of the hierarchy and applied it to its financial assets and liabilities. At December 31, 2019 and 2018, there were no assets or liabilities carried or measured at fair value. |
Use of Estimates and Assumptions | Use of Estimates and Assumptions The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. A material estimate that is particularly susceptible to significant change in the near-term relate to the determination of the impairment of IPRD. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make this estimate. Although considerable variability is likely to be inherent in this estimate, management believes that the amount provided is reasonable. This estimate is continually reviewed and adjusted if necessary. Such adjustments, if any, are reflected in operations. |
Sale Of Custom Pool (Tables)
Sale Of Custom Pool (Tables) | 12 Months Ended |
Dec. 31, 2019 | |
Disclosure Sale Of Custom Pool Tables Abstract | |
Schedule of Reconciliation of Discontinued Operations | The following is a reconciliation of the major line items constituting income of discontinued operations, net that are presented in the accompanying Consolidated Statements of Operations: Years Ended December 31, 2019 2018 Major Classes of Line Items Constituting Pre-Tax Income on Discontinued Operations: Revenue $ — $ 1,786,911 Cost of Services — 1,208,619 General and Administrative — 338,877 Other Operating Expenses — 51,370 Total Operating Expenses — 1,598,866 Operating Income — 188,045 Other Expense — 9,745 Total Pre-Tax Income from Discontinued Operations — 178,300 Income Tax Expense — (37,367 ) Income from Discontinued Operations $ — $ 140,933 |
Summary Of Significant Accoun_3
Summary Of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2019 | |
Summary Of Significant Accounting Policies | |
Schedule of Earnings Per Share Basic and Diluted | For the years ended December 31, 2019 and 2018, the basic and diluted net loss per share from continuing operations, the basic and diluted net earnings from discontinued operations and the basic and diluted net loss per share were computed as follows: Year Ended December 31, 2019 2018 Loss from Continuing Operations, net $ (2,305,073 ) $ (7,767,532 ) Income from Discontinued Operations, net — 140,933 Net Loss Available to Common Stockholders (2,305,073 ) (7,626,599 ) Series A Preferred Stock Dividends 10,000 10,000 Net Loss Available to Common Stockholders and Assumed Conversions $ (2,315,073 ) $ (7,636,599 ) Weighted Average Shares - Basic 71,297,272 73,771,722 Effective Dilutive Securities – Stock Options — — Shares Issuable Upon Conversion of Convertible Promissory Notes — — Shares Issuable Upon Conversion of Preferred Stock – Series A — — Shares Issuable Upon Conversion of Preferred Stock – Series B — — Weighted Average Shares - Diluted 71,297,272 73,771,722 Net Loss Per Common Share from Continuing Operations: Basic $ (0.03 ) $ (0.11 ) Diluted $ (0.03 ) $ (0.11 ) Net Earnings Per Common Share from Discontinued Operations: Basic $ — $ — Diluted $ — $ — Net Loss Per Common Share: Basic $ (0.03 ) $ (0.10 ) Diluted $ (0.03 ) $ (0.10 ) |
Fair Value Of Estimates (Tables
Fair Value Of Estimates (Tables) | 12 Months Ended |
Dec. 31, 2019 | |
Fair Value Of Estimates | |
Schedule of Fair Value of Cash, Notes Payable and Loans | The estimated fair value of the cash, notes payable, and loans at December 31, 2019 and 2018, were as follows: Quoted Prices In Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Carrying Value At December 31, 2019: Assets Cash $ 1,159 — — $ 1,159 Liabilities — — 8% Senior Secured Convertible Promissory Note, Net — — $ 694,431 $ 694,431 8% Senior Secured Convertible Promissory Note issued December 2, 2019, Net — — $ 24,093 $ 24,093 Loan from MAAB — — $ 750,017 $ 750,017 At December 31, 2018: Assets Cash $ 55,129 — — $ 55,129 Liabilities 8% Senior Secured Convertible Promissory Note, Net — — $ 108,886 $ 108,886 Loan from MAAB — — $ 591,439 $ 591,439 |
Income Tax (Tables)
Income Tax (Tables) | 12 Months Ended |
Dec. 31, 2019 | |
Disclosure Organziation And Summary Of Significiant Accounting Policies Tables Abstract | |
Schedule of Income Tax Rates and the Statutory Federal Rates from Continuing Operations | A reconciliation of differences between the effective income tax rates and the statutory federal rates from continuing operations is as follows: 2019 2018 Rate Amount Rate Amount Income Tax benefit at US statutory Rate 21 % $ 484,065 21 % $ 1,631,172 State taxes, net of federal benefit 5 % 114,471 3 % 263,914 Change in valuation allowance (26 )% (598,546 ) (24 )% (1,895,086 ) $ — $ — |
Schedule of Statutory Federal Income Tax Rate for Discontinued Operations | The differences between the statutory Federal income tax rate and the effective tax rate are summarized as follows for the year ended December 31, 2018 for discontinued operations: Income Taxes (benefit) at Statutory Rate $ 37,443 21.0 % Increase (Decrease) in Taxes Resulting From: State Taxes, net of Federal Tax Benefit (76 ) — Graduated Tax Rates — — Reduction in Federal Income Tax Rate — — Other, Net — — Income Taxes $ 37,367 21.0 % |
Schedule of Deferred Tax Assets | Significant components of the Company’s deferred tax assets and liabilities are as follows: December 31, 2019 2018 Deferred Income Tax Assets (Liabilities): Net Operational Loss Carryforwards $ 703,548 $ 165,505 Intangible Assets 1,415,989 1,522,188 Research & Development Costs 366,868 228,699 Other, Net 7,227 (21,296 ) Gross Deferred Income Tax Assets (Liabilities) $ 2,493,632 $ 1,895,096 Less: Valuation Allowance (2,493,632 ) (1,895,096 ) Net Deferred Income Tax Asset $ — $ — |
Warrants (Tables)
Warrants (Tables) | 12 Months Ended |
Dec. 31, 2019 | |
Disclosure Warrants Tables Abstract | |
Schedule of Warrants Activity | A summary of the warrant activity follows: Warrants outstanding Exercise price per share Price per Share on Date of Issuance Balance, December 31, 2018 13,674,029 0.51 – 0.75 0.57 – 1.00 Granted 421,656 0.40 0.33 Expired — — — Balance, December 31, 2019 14,095,685 0.40 – 0.75 0.33 – 1.00 |
2014 Stock Award Plan (Tables)
2014 Stock Award Plan (Tables) | 12 Months Ended |
Dec. 31, 2019 | |
Stock Award Plan | |
A Summary of Stock Option Activity | A summary of the stock option activity over the years ended December 31, 2019 and 2018 is as follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2017 3,250,000 $ 0.037 3.3 Years $ 56,125 Options Cancelled (3,250,000 ) — — — Outstanding at December 31, 2018 — — — — Exercisable at December 31, 2018 — — — — Outstanding at December 31, 2019 — — — — Exercisable at December 31, 2019 — — — — The Company expensed $22,857 of stock option compensation during the year ended December 31, 2018. |
Sale Of Custom Pool (Details)
Sale Of Custom Pool (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Major Classes of Line Items Constituting Pre-Tax Income on Discontinued Operations: | ||
Revenue | $ 1,786,911 | |
Cost of Services | 1,208,619 | |
General and Administrative | 338,877 | |
Other Operating Expenses | 51,370 | |
Total Operating Expenses | 1,598,866 | |
Operating Income | 188,045 | |
Other Expense | 9,745 | |
Total Pre-Tax Loss from Discontinued Operations | 178,300 | |
Income Tax Expense | 37,367 | |
Loss from Discontinued Operations | $ 140,933 |
Summary Of Significant Accoun_4
Summary Of Significant Accounting Policies (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Disclosure Summary Of Significant Accounting Policies Details Abstract | ||
Loss from Continuing Operations, net | $ (2,305,073) | $ (7,767,532) |
Income from Discontinued Operations, net | 140,933 | |
Net Loss Available to Common Stockholders | (2,305,073) | (7,626,599) |
Series A Preferred Stock Dividends | 10,000 | 10,000 |
Net Loss Available to Common Stockholders and Assumed Conversions | $ (2,315,073) | $ (7,636,599) |
Weighted Average Shares - Basic | 71,297,272 | 73,771,722 |
Effective Dilutive Securities – Stock Options | ||
Shares Issuable Upon Conversion of Convertible Promissory Notes | ||
Shares Issuable Upon Conversion of Preferred Stock – Series A | ||
Shares Issuable Upon Conversion of Preferred Stock – Series B | ||
Weighted Average Shares - Diluted | 71,297,272 | 73,771,722 |
Net Loss Per Common Share from Continuing Operations: | ||
Basic | $ (0.03) | $ (0.11) |
Diluted | (0.03) | (0.11) |
Net Earnings Per Common Share from Discontinued Operations: | ||
Basic | ||
Diluted | ||
Net Loss Per Common Share: | ||
Basic | (0.03) | (0.10) |
Diluted | $ (0.03) | $ (0.10) |
Fair Value Of Estimates (Detail
Fair Value Of Estimates (Details) - USD ($) | Dec. 31, 2019 | Dec. 31, 2018 |
Liabilities | ||
8% Senior Secured Convertible Promissory Note, Net | $ 694,431 | $ 108,886 |
8% Senior Secured Convertible Promissory Note issued December 2, 2019, Net | 24,093 | |
Loan from MAAB | 750,017 | 591,439 |
Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ||
Assets | ||
Cash | 1,159 | 55,129 |
Liabilities | ||
8% Senior Secured Convertible Promissory Note, Net | ||
8% Senior Secured Convertible Promissory Note issued December 2, 2019, Net | ||
Loan from MAAB | ||
Significant Other Observable Inputs (Level 2) [Member] | ||
Assets | ||
Cash | ||
Liabilities | ||
8% Senior Secured Convertible Promissory Note, Net | ||
8% Senior Secured Convertible Promissory Note issued December 2, 2019, Net | ||
Loan from MAAB | ||
Significant Unobservable Inputs (Level 3) [Member] | ||
Assets | ||
Cash | ||
Liabilities | ||
8% Senior Secured Convertible Promissory Note, Net | 694,431 | 108,886 |
8% Senior Secured Convertible Promissory Note issued December 2, 2019, Net | 24,093 | |
Loan from MAAB | 750,017 | 591,439 |
Significant Unobservable Inputs - Carrying Value [Member] | ||
Assets | ||
Cash | 1,159 | 55,129 |
Liabilities | ||
8% Senior Secured Convertible Promissory Note, Net | 694,431 | 108,886 |
8% Senior Secured Convertible Promissory Note issued December 2, 2019, Net | 24,093 | |
Loan from MAAB | $ 750,017 | $ 591,439 |
Income Tax (Schedule Of Income
Income Tax (Schedule Of Income Tax Rates From Continuing Operations) (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Income Tax Schedule Of Income Tax Rates From Continuing Operations | ||
Income Tax benefit at US statutory Rate | $ 484,065 | $ 1,631,172 |
State income tax, net of federal benefit | 114,471 | 263,914 |
Change in valuation allowances | $ (598,546) | $ (1,895,086) |
Income Tax benefit at US statutory Rate-Percent | 21.00% | 21.00% |
State income tax, net of federal benefit-Percent | 5.00% | 3.00% |
Change in valuation allowances-Percent | (26.00%) | 24.00% |
Income Tax (Schedule Of Statuto
Income Tax (Schedule Of Statutory Income Tax Rate From Discontinued Operations) (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Income Taxes (benefit) at Statutory Rate | $ 484,065 | $ 1,631,172 |
Increase (Decrease) in Taxes Resulting From: | ||
State Taxes, net of Federal Tax Benefit | $ 114,471 | $ 263,914 |
Income Taxes (benefit) at Statutory Rate-Percent | 21.00% | 21.00% |
Increase (Decrease) in Taxes Resulting From: | ||
State Taxes, net of Federal Tax Benefit-Percent | 5.00% | 3.00% |
Income Tax For Dicontinued Operations [Member] | ||
Income Taxes (benefit) at Statutory Rate | $ 37,443 | |
Increase (Decrease) in Taxes Resulting From: | ||
State Taxes, net of Federal Tax Benefit | (76) | |
Graduated Tax Rates | ||
Reduction in Federal Income Tax Rate | ||
Other, Net | ||
Income Taxes | $ 37,367 | |
Income Taxes (benefit) at Statutory Rate-Percent | 21.00% | |
Increase (Decrease) in Taxes Resulting From: | ||
State Taxes, net of Federal Tax Benefit-Percent | ||
Graduated Tax Rates-Percent | ||
Reduction in Federal Income Tax Rate-Percent | ||
Other, Net-Percent | ||
Income Taxes-Percent | 21.00% |
Income Tax (Schedule Of Deferre
Income Tax (Schedule Of Deferred Tax Assets) (Details) - USD ($) | Dec. 31, 2019 | Dec. 31, 2018 |
Deferred Income Tax Assets (Liabilities): | ||
Net Operational Loss Carryforwards | $ 703,548 | $ 165,505 |
Intangible Assets | 1,415,989 | 1,522,188 |
Research & Development Costs | 366,868 | 228,699 |
Other, Net | 7,227 | (21,296) |
Gross Deferred Income Tax Assets (Liabilities) | 2,493,632 | 1,895,096 |
Less: Valuation Allowance | 2,493,632 | 1,895,096 |
Net Deferred Income Tax Asset |
Warrants (Details)
Warrants (Details) - Warrant [Member] | 12 Months Ended |
Dec. 31, 2019$ / sharesshares | |
Warrants Outstanding | |
Outstanding -beginning of year | shares | 13,674,029 |
Granted | shares | 421,656 |
Expired | shares | |
Outstanding - end of year | shares | 14,095,685 |
Exercise Price Per Share | |
Granted | $ 0.40 |
Expired | |
Price Per Share On Date Of Issuance | |
Granted | .33 |
Expired | |
Minimum [Member] | |
Warrants Outstanding | |
Granted | shares | 0 |
Exercise Price Per Share | |
Outstanding -beginning of year | $ 0.51 |
Outstanding - end of year | 0.40 |
Price Per Share On Date Of Issuance | |
Outstanding -beginning of year | 0.57 |
Outstanding - end of year | $ .33 |
Maximum [Member] | |
Warrants Outstanding | |
Granted | shares | 0 |
Exercise Price Per Share | |
Outstanding -beginning of year | $ 0.75 |
Outstanding - end of year | 0.75 |
Price Per Share On Date Of Issuance | |
Outstanding -beginning of year | 1 |
Outstanding - end of year | $ 1 |
2014 Stock Award Plan (Details)
2014 Stock Award Plan (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Number of Options | ||
Outstanding -beginning of the year | 3,250,000 | |
Options Cancelled | 3,250,000 | |
Outstanding - end of the year | ||
Exercisable at the end of the year | ||
Weighted Average Exercise Price | ||
Outstanding -beginning of the year | $ 0.037 | |
Options Cancelled | ||
Outstanding - end of the year | ||
Excercisable at the end of the year | ||
Weighted-Average Remaining Contractual Term (years) | ||
Outstanding - beginning of the year | 3 years 3 months 18 days | |
Aggregate Intrinsic Value | ||
Outstanding - beginning of the year | $ 56,125 |
Nature Of Operations (Narrative
Nature Of Operations (Narrative) (Details) - USD ($) | Dec. 31, 2019 | May 21, 2019 | Dec. 31, 2018 |
Working capital | $ (921,829) | ||
Promissory note from MAAB | 750,017 | $ 591,439 | |
8% senior convertible promissory note | 694,431 | 108,886 | |
Promissory Notes Payable [Member] | MAAB Global Limited (MAAB), Parent Company [Member] | |||
Promissory note from MAAB | 750,017 | $ 591,439 | |
Amount available under the terms of the note | 499,983 | ||
8% Senior Secured Convertible Promissory Note - First Tranche [Member] | |||
8% senior convertible promissory note | 983,524 | $ 307,798 | |
8% Senior Secured Convertible Promissory Note - Second Tranche [Member] | |||
8% senior convertible promissory note | $ 149,546 |
Sale Of Common Stock Of Major_2
Sale Of Common Stock Of Majority Stockholders And Resignation And Election Of The Board Of Directors (Narrative) (Details) - MAAB Global Limited (MAAB) [Member] | Mar. 14, 2018shares |
Common Stock [Member] | |
Sale of stock by majority stockholders | 51,711,571 |
Percentage of shares held by Parent | 62.35% |
Preferred Stock [Member] | |
Sale of stock by majority stockholders | 1,562,500 |
Percentage of shares held by Parent | 100.00% |
Acqusition Of Assets From Con_2
Acqusition Of Assets From Confida Aerospace Ltd (Narrative) (Details) - USD ($) | May 08, 2018 | May 04, 2018 | Dec. 31, 2019 | Dec. 31, 2018 |
Fair market value of preferred stock | $ (876,440) | |||
Impairment expense | 6,285,214 | |||
Acquired in-process research and development | $ 871,000 | 871,000 | ||
Common Stock [Member] | ||||
Fair market value of preferred stock | (13,669) | |||
Series B Convertible Preferred Stock [Member] | ||||
Preferred stock conversion terms | Each share of Preferred is convertible into 1,333 shares of common stock and a five year warrant to purchase 1,333 shares of common stock at an exercise price of $0.75 per share. | |||
Fair market value of preferred stock | ||||
Asset Purchase Agreement With Confida Aerospace Ltd [Member] | ||||
Agreement description | On May 8, 2018, the Company entered into an Asset Purchase Agreement with Confida Aerospace Ltd. Pursuant to the Asset Purchase Agreement, the Company purchased in-process research and development (“IPRD”) consisting of inventory, hardware designs, software designs, and a trademark all pertaining to passenger drone design and use from Confida Aerospace Ltd. As consideration for the Asset Purchase Agreement, the Company issued Confida Aerospace Ltd., 10,000 of the Company’s Series B preferred shares (See, Note 13, “Convertible Preferred Stock”). Each preferred share is convertible into 1,333 common shares and 1,333 warrants. Each warrant is exercisable into one of the Company’s common shares at an exercise price of $.75. The warrants have an exercise period of five years upon As well, after the initial 90 day period for the assumption of liabilities, the Company determined that it would most likely only assume $25,000 of liabilities and has adjusted the consolidated financial statements accordingly. During 2018, the expenses related to the liabilities had been incurred and the impairment expense was reduced by $25,000 to $6,285,214. | |||
Debts assumed | $ 50,000 | |||
Impairment expense | 6,310,214 | |||
Acquired in-process research and development | $ 871,000 | |||
Asset Purchase Agreement With Confida Aerospace Ltd [Member] | Common Stock [Member] | ||||
Weighted average stock price | $ 0.46 | |||
Fair value of common stock | $ 3,753,271 | |||
Asset Purchase Agreement With Confida Aerospace Ltd [Member] | Warrant [Member] | ||||
No of common shares called by each warrant | 1 | |||
Exercise price of warrants | $ 75 | |||
Warrant terms | 5 years | |||
Weighted average stock price | $ 0.46 | |||
Fair value assumption methodology | Black scholes model | |||
Exercise price | $ 0.75 | |||
Weighted average term | 10 years | |||
Risk free rate | 2.97% | |||
Volatility | 51.00% | |||
Dividend yield | 0.00% | |||
Fair value of warrants | $ 3,377,943 | |||
Asset Purchase Agreement With Confida Aerospace Ltd [Member] | Series B Convertible Preferred Stock [Member] | ||||
No of preferred stock issued in consideration for the asset purchase agreement | 10,000 | |||
Preferred stock conversion terms | Each preferred share is convertible into 1,333 common shares and 1,333 warrants. | |||
Fair market value of preferred stock | $ 7,131,214 |
8% Senior Secured Convertible_2
8% Senior Secured Convertible Promissory Note (Narrative) (Details) - USD ($) | Jan. 29, 2020 | Jan. 03, 2020 | Dec. 02, 2019 | Sep. 11, 2019 | May 21, 2019 | Mar. 19, 2019 | Feb. 22, 2019 | Feb. 12, 2019 | Nov. 21, 2018 | Dec. 31, 2019 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Dec. 31, 2019 | Dec. 31, 2018 | May 29, 2020 |
Debt Instrument [Line Items] | ||||||||||||||||
Common stock, shares authorized | 250,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | ||||||||||||
Stock issued as additional consideration for debt, value | ||||||||||||||||
Amortization of debt discount | $ 1,191,894 | $ 295,398 | ||||||||||||||
Common Stock [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Stock issued as additional consideration for debt, shares | 156,250 | |||||||||||||||
Stock issued as additional consideration for debt, value | $ 156 | |||||||||||||||
Subsequent Event [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Common stock, shares authorized | 250,000,000 | |||||||||||||||
Common shares available to be issued | 88,882,955 | |||||||||||||||
8% Senior Secured Convertible Promissory Note [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Debt instrument face amount | $ 575,682 | $ 1,383,636 | ||||||||||||||
Total investment | $ 1,200,000 | |||||||||||||||
Debt instrument interest rate | 8.00% | |||||||||||||||
Debt instrument description | The initial tranche principal of $149,546 was issued, with an OID of $17,046, the pro-rated portion of the $68,182 OID for the entire principal amount of $575,682, a $7,500 financing fee for the lender’s transactional expenses that was expensed and the Company received proceeds of $125,000 | The Company and the Investor promptly began negotiations on a Forbearance Agreement and on September 11, 2019, the Company and the Investor agreed to a Forbearance Agreement. Pursuant to this agreement, the Investor is willing to postpone pursuing its rights and remedies under the agreements, in particular and without limitation with respect to the acceleration of the promissory note and the immediate payment of the default amount and reduce the balance of the promissory note to the pre-default balance plus accrued non-default interest of $1,062,784 on the following terms: 1) subject to the Company’s compliance with the forbearance agreement, the forbearance shall commence on the effective date and will expire on June 30, 2020. 2) Should the Company fail to abide by any of the terms and conditions of the forbearance agreement, fail to comply with the terms of the other agreements, or fail to timely make the payments required under the promissory notes, or should the Company trigger an event of default, the forbearance period will immediately terminate. 3) Subject to the Company’s compliance with the forbearance period, the repayment of the promissory note will be reduced from 35% to 0%. | The Note was issued with two $600,000 tranches of cash payments. Since both tranches are in one Note, both tranches are in default as of May 21, 2019. | On November 21, 2018, the Company issued an 8% Senior Secured Convertible Promissory Note in the aggregate principal amount of $1,383,636 in exchange for a total investment of $1,200,000, less commissions and expenses, payable in two tranches. The first tranche was payable upon the closing of the agreement, and the second tranche was payable within ten (10) business days of the Investor receiving written notice confirming the effectiveness of the initial registration statement. | ||||||||||||
Original issue discount | $ 132,500 | |||||||||||||||
Debt instrument maturity description | Each tranche matures 6 months after the issue date | |||||||||||||||
Debt instrument maturity date | Jun. 2, 2020 | Jun. 30, 2020 | ||||||||||||||
Debt instrument conversion terms | The Note is convertible into common shares of the Company at a price equal to 75% of the lowest market value in the thirty trading days prior to the conversion date, which created a BCF valued at greater than the total principal amount of the Note issued of $149,546. The conversion price was $0.0375 per share which converts into 3,987,880 common shares. The common stock price at the valuation date was $0.13 per share, so that the BCF was calculated to be $0.0925 per share valuing the BCF at $368,879. | The Note is convertible into common shares of the Company at a price equal to 75% of the lowest market value in the thirty trading days prior to the conversion date. The Company is subject to certain penalties if the shares are not issued within two business days of receiving the conversion notice. | ||||||||||||||
Debt instrument collateral terms | Pursuant to a Security Agreement between the Company and the Investor (the “Security Agreement”), the Company has granted to the Investor a security interest in its assets to secure repayment of the Notes. The Company must reserve an amount of shares equal to 500% of the total amount of shares issuable upon full conversion of the promissory note. The Company meets this requirement since it has 250,000,000 common shares authorized and as of May 26, 2020, 88,882,955 shares available to be issued. | |||||||||||||||
Debt instrument beneficial conversion feature fair value | $ 149,546 | |||||||||||||||
Conversion price per share | $ 0.0375 | |||||||||||||||
Amortization of debt discount | $ 125,453 | |||||||||||||||
No of shares issued in conversion of debt | 1,871,515 | |||||||||||||||
Stock price at valuation date | $ 0.13 | |||||||||||||||
Additional debt discount into interest expenses | 24,093 | |||||||||||||||
Accrued interest | $ 1,927 | |||||||||||||||
8% Senior Secured Convertible Promissory Note [Member] | Common Stock [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Debt instrument conversion terms | However, the conversion share calculation was incorrect for the March 19, 2019 conversion of the $38,633 in principal amount of the Note and was 26,712 shares less than what it should have been. These shares were added to a subsequent conversion in April 2019. | |||||||||||||||
Value of principal portion of debt converted into shares of common stock | $ 38,633 | $ 55,387 | $ 20,000 | $ 93,830 | $ 449,397 | |||||||||||
No of shares issued in conversion of debt | 3,987,880 | 150,000 | 215,054 | 491,099 | 750,000 | 1,830,373 | ||||||||||
8% Senior Secured Convertible Promissory Note [Member] | Subsequent Event [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Conversion price per share | $ 0.053175 | $ 0.04 | ||||||||||||||
Value of principal portion of debt converted into shares of common stock | $ 150,000 | $ 16,724 | ||||||||||||||
No of shares issued in conversion of debt | 2,820,874 | 406,908 | ||||||||||||||
8% Senior Secured Convertible Promissory Note - First Tranche [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Debt instrument face amount | $ 701,818 | |||||||||||||||
Original issue discount | 81,818 | |||||||||||||||
Financing fee | 20,000 | |||||||||||||||
Proceeds from senior convertible promissory note | $ 600,000 | |||||||||||||||
Debt instrument maturity date | May 21, 2019 | |||||||||||||||
Debt instrument beneficial conversion feature fair value | $ 523,326 | |||||||||||||||
Total debt discount | 694,447 | |||||||||||||||
Unamortized debt discount | $ 865,796 | 88,022 | $ 88,022 | 88,022 | ||||||||||||
Conversion price per share | $ 0.375 | |||||||||||||||
Amortization of debt discount | $ 163,978 | 534,682 | $ 108,886 | |||||||||||||
Stock price at valuation date | $ 0.57 | |||||||||||||||
Accrued interest | $ 24,118 | |||||||||||||||
8% Senior Secured Convertible Promissory Note - First Tranche [Member] | Warrant [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
No of common shares called by warrants | 344,029 | |||||||||||||||
Exercise price of warrants | $ 0.51 | |||||||||||||||
Warrant terms | 5 years | |||||||||||||||
Fair value of warrants | $ 171,121 | |||||||||||||||
8% Senior Secured Convertible Promissory Note - First Tranche [Member] | Common Stock [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Stock issued as additional consideration for debt, shares | 156,250 | |||||||||||||||
Stock issued as additional consideration for debt, value | $ 89,531 | |||||||||||||||
8% Senior Secured Convertible Promissory Note - Second Tranche [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Debt instrument face amount | $ 681,818 | |||||||||||||||
Original issue discount | 81,818 | |||||||||||||||
Proceeds from senior convertible promissory note | $ 600,000 | |||||||||||||||
Debt instrument maturity date | Aug. 12, 2019 | |||||||||||||||
Debt instrument beneficial conversion feature fair value | $ 403,689 | |||||||||||||||
Total debt discount | 525,009 | |||||||||||||||
Unamortized debt discount | $ 606,827 | 108,425 | 108,425 | 108,425 | ||||||||||||
Amortization of debt discount | 498,402 | |||||||||||||||
8% Senior Secured Convertible Promissory Note - Second Tranche [Member] | Warrant [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
No of common shares called by warrants | 421,656 | |||||||||||||||
Exercise price of warrants | $ 0.40 | |||||||||||||||
Warrant terms | 5 years | |||||||||||||||
Fair value of warrants | $ 121,320 | |||||||||||||||
Amortization of debt discount | 230,843 | |||||||||||||||
Additional debt discount into interest expenses | 117,986 | |||||||||||||||
First 8% Senior Secured Convertible Promissory Note [Member] | ||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||
Accrued interest | $ 83,557 | $ 83,557 | $ 83,557 |
Default And Forbearance On Th_2
Default And Forbearance On The 8% Senior Secured Convertible Promissory Note (Narrative) (Details) - USD ($) | Dec. 02, 2019 | Sep. 11, 2019 | May 21, 2019 | Nov. 21, 2018 | Dec. 31, 2019 | Dec. 31, 2018 |
Debt Instrument [Line Items] | ||||||
8% senior convertible promissory note | $ 694,431 | $ 108,886 | ||||
8% Senior Secured Convertible Promissory Note - First Tranche [Member] | ||||||
Debt Instrument [Line Items] | ||||||
8% senior convertible promissory note | $ 307,798 | 983,524 | ||||
Accrued interest | $ 24,118 | |||||
Debt default terms | The Company was unable to repay the principal and accrued interest and therefore was in default of the Note. The Note has default provisions permitting default interest of 18% to be charged on the Note as well as to charge a default amount of 150% of the unpaid principal and interest. | |||||
Debt instrument maturity date | May 21, 2019 | |||||
8% Senior Secured Convertible Promissory Note [Member] | ||||||
Debt Instrument [Line Items] | ||||||
8% senior convertible promissory note | $ 805,649 | |||||
Accrued interest | $ 1,927 | |||||
Debt instrument description | The initial tranche principal of $149,546 was issued, with an OID of $17,046, the pro-rated portion of the $68,182 OID for the entire principal amount of $575,682, a $7,500 financing fee for the lender’s transactional expenses that was expensed and the Company received proceeds of $125,000 | The Company and the Investor promptly began negotiations on a Forbearance Agreement and on September 11, 2019, the Company and the Investor agreed to a Forbearance Agreement. Pursuant to this agreement, the Investor is willing to postpone pursuing its rights and remedies under the agreements, in particular and without limitation with respect to the acceleration of the promissory note and the immediate payment of the default amount and reduce the balance of the promissory note to the pre-default balance plus accrued non-default interest of $1,062,784 on the following terms: 1) subject to the Company’s compliance with the forbearance agreement, the forbearance shall commence on the effective date and will expire on June 30, 2020. 2) Should the Company fail to abide by any of the terms and conditions of the forbearance agreement, fail to comply with the terms of the other agreements, or fail to timely make the payments required under the promissory notes, or should the Company trigger an event of default, the forbearance period will immediately terminate. 3) Subject to the Company’s compliance with the forbearance period, the repayment of the promissory note will be reduced from 35% to 0%. | The Note was issued with two $600,000 tranches of cash payments. Since both tranches are in one Note, both tranches are in default as of May 21, 2019. | On November 21, 2018, the Company issued an 8% Senior Secured Convertible Promissory Note in the aggregate principal amount of $1,383,636 in exchange for a total investment of $1,200,000, less commissions and expenses, payable in two tranches. The first tranche was payable upon the closing of the agreement, and the second tranche was payable within ten (10) business days of the Investor receiving written notice confirming the effectiveness of the initial registration statement. | ||
Debt instrument maturity date | Jun. 2, 2020 | Jun. 30, 2020 | ||||
Forbearance agreement outstanding principal and accrued interest | $ 1,062,784 | |||||
Forbearance penalty | $ 257,135 | |||||
Amortization of forbearance penalty | 97,747 | |||||
First 8% Senior Secured Convertible Promissory Note [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Accrued interest | 83,557 | |||||
Debt instrument carrying amount | $ 983,524 |
Convertible Promissory Notes (N
Convertible Promissory Notes (Narrative) (Details) - Former Option Holders [Member] - USD ($) | Sep. 18, 2018 | Mar. 14, 2018 |
Two 10% Convertible Promissory Notes [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument description | On March 14, 2018, 1,500,000 stock options were cancelled and two 10% Convertible Promissory Notes (“Notes”) with a six month maturity were issued to the former option holders. | |
Debt instrument interest rate | 10.00% | |
Debt instrument conversion terms | The Notes were convertible into the Company’s common stock based upon the average of the previous ten trading days’ closing price of the stock, at the maturity date of the Notes. Upon conversion of the notes, Bruce Bent or MAAB Global Limited had the option to purchase the common stock issued at a 5% discount to the average closing price of the stock over the previous 10 trading days. The option to purchase expired ten days after the issuance of the common stock. The option was not exercised. | |
No of shares issued in conversion of debt | 38,886 | |
Accrued interest portion of debt converted into shares of common stock | $ 2,534 | |
10% Convertible Promissory Note - One [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument face amount | $ 25,000 | |
10% Convertible Promissory Note - Two [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument face amount | $ 25,000 |
Promissory Note From MAAB (Narr
Promissory Note From MAAB (Narrative) (Details) - USD ($) | Mar. 14, 2018 | Dec. 31, 2019 | Dec. 31, 2018 |
Debt Instrument [Line Items] | |||
Promissory note from MAAB | $ 750,017 | $ 591,439 | |
Promissory Notes Payable [Member] | MAAB Global Limited (MAAB), Parent Company [Member] | |||
Debt Instrument [Line Items] | |||
Debt instrument maximum borrowing capacity | $ 750,000 | ||
Debt instrument maturity date | Feb. 28, 2021 | ||
Debt instrument interest rate terms | The Promissory Note has an interest charge of 10%, compounded monthly. Interest accrues on the principal amount or portion thereof which remains unpaid from time to time as well as any interest outstanding, from the date the principal amount is advanced until and including the date upon which the principal amount and all interest due under this promissory note shall be fully paid. | ||
Promissory note from MAAB | 750,017 | 591,439 | |
Accrued interest | $ 89,797 | $ 41,291 |
Income Tax (Narrative) (Details
Income Tax (Narrative) (Details) | 12 Months Ended |
Dec. 31, 2019USD ($) | |
Income Tax Narrative | |
Net operating loss carryforward | $ 2,776,000 |
Operating loss carryforward limitations on use | Offset future taxable income with no expiration |
Percentage of valuation allowance | 100.00% |
Convertible Preferred Stock (Na
Convertible Preferred Stock (Narrative) (Details) - USD ($) | May 04, 2018 | Jan. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2019 |
Series A Convertible Preferred Stock [Member] | ||||
Preferred stock, shares authorized | 50,000,000 | |||
Preferred stock, par value per share | $ 0.0001 | |||
Preferred stock liquidation value | $ 0 | |||
Preferred stock dividend rate | 8.00% | |||
Preferred stock dividend terms | The Series A Preferred has an 8% dividend paid quarterly | |||
Preferred stock conversion terms | Convertible into one share of common stock. | |||
Series A Convertible Preferred Stock [Member] | MAAB Global Limited (MAAB) [Member] | ||||
Cumulative undeclared series A preferred dividends | $ 17,500 | |||
Series A Convertible Preferred Stock [Member] | Lawrence & Loreen Calarco, Former Officers And Directors [Member] | ||||
Preferred stock issued | 1,562,500 | |||
Series B Convertible Preferred Stock [Member] | ||||
Preferred stock, shares authorized | 10,000 | |||
Preferred stock, par value per share | $ 0.001 | |||
Preferred stock dividend terms | The Preferred is entitled to a dividend, when declared by the Board of Directors, votes with all other classes of stock as a single class of stock on all actions to be voted on by the stockholders of the Company | |||
Preferred stock conversion terms | Each share of Preferred is convertible into 1,333 shares of common stock and a five year warrant to purchase 1,333 shares of common stock at an exercise price of $0.75 per share. | |||
Preferred stock liquidation preference | Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, the holders of the shares of the Series B Preferred Stock shall share pro rata with the holders of the common stock, on an as if converted basis. |
Warrants (Narrative) (Details)
Warrants (Narrative) (Details) - Warrant [Member] - USD ($) | Feb. 12, 2019 | Nov. 21, 2018 |
8% Senior Secured Convertible Promissory Note - First Tranche [Member] | ||
Fair value assumptions - warrants: | ||
Fair value assumption methodology | Black scholes model | |
Stock price | $ 0.57 | |
Strike price | $ 0.51 | |
Time to expiration | 5 years | |
Five year treasury constant maturity rate | 2.33% | |
Volatility | 253.00% | |
Dividend yield | 0.00% | |
Fair value of each warrant | $ 0.5676 | |
Fair value of warrant in aggregate | $ 195,271 | |
8% Senior Secured Convertible Promissory Note - Second Tranche [Member] | ||
Fair value assumptions - warrants: | ||
Fair value assumption methodology | Black scholes model | |
Stock price | $ 0.33 | |
Strike price | $ 0.40 | |
Time to expiration | 5 years | |
Five year treasury constant maturity rate | 2.34% | |
Volatility | 173.00% | |
Dividend yield | 0.00% | |
Fair value of each warrant | $ 0.35 | |
Fair value of warrant in aggregate | $ 147,580 |
Equity Purchase Agreement And_2
Equity Purchase Agreement And Registration Rights Agreement (Narrative) (Details) - Equity Purchase And Registration Rights Agreement [Member] - USD ($) | Dec. 31, 2019 | Aug. 26, 2019 |
Agreement description | Subsequent to the Agreement and prior to the issuance of the Commitment Shares, the Company renegotiated the payment to 300,000 shares of common stock. | Under the terms of the Equity Purchase Agreement, the Investor agreed to purchase from the Company up to $5,000,000 of the Company’s common stock upon effectiveness of a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission and subject to certain limitations and conditions set forth in the Equity Purchase Agreement. Following effectiveness of the Registration Statement, and subject to certain limitations and conditions set forth in the Equity Purchase Agreement, the Company shall have the discretion to deliver put notices to the Investor and the Investor will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to the Investor in each put notice shall not exceed the lesser of $500,000 or one hundred fifty percent (150%) of the average daily trading volume of the Company’s Common Stock during the ten (10) trading days preceding the put notice. Pursuant to the Equity Purchase Agreement, the Investor and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to the Investor that would result in the Investor’s beneficial ownership of the Company’s outstanding Common Stock exceeding 9.99%. The price of each put share shall be equal to eighty five percent (85%) of the Market Price (as defined in the Equity Purchase Agreement). Puts may be delivered by the Company to the Investor until the earlier of (i) the date on which the Investor has purchased an aggregate of $5,000,000 worth of Common Stock under the terms of the Equity Purchase Agreement, (ii) August 26, 2022, or (iii) written notice of termination delivered by the Company to the Investor, subject to certain equity conditions set forth in the Equity Purchase Agreement. |
Agreed value of shares to be purchased under the agreement | $ 5,000,000 | |
No of shares committed to be issued under the agreement | 600,000 | |
Fair value of commitment shares recorded as deferred offering cost | $ 48,300 |
2014 Stock Awards Plan (Narrati
2014 Stock Awards Plan (Narrative) (Details) - USD ($) | Mar. 14, 2018 | Nov. 30, 2014 | Dec. 31, 2019 | Dec. 31, 2018 |
Stock options cancelled | 3,250,000 | |||
Shares available for issuance | 7,000,000 | |||
Stock option compensation | $ 22,857 | |||
2014 Stock Awards Plan [Member] | Stock Options [Member] | ||||
Shares authorized to be issued under stock awards plan | 7,000,000 | |||
Stock awards plan description | For incentive stock options, at the grant date the stock options exercise price is required to be at least 110% of the fair value of the Company’s common stock. The Plan permits the grants of common stock or options to purchase common stock. As plan administrator, the Board of Directors has sole discretion to set the price of the options. Further, the Board of Directors may amend or terminate the plan. | |||
Stock options cancelled | 3,250,000 | |||
2014 Stock Awards Plan [Member] | Stock Options [Member] | Two 10% Convertible Promissory Notes [Member] | ||||
Stock options exchanged for debt | 1,500,000 |
Section 16(A) Beneficial Owne_2
Section 16(A) Beneficial Ownership Reporting Compliance (Narrative) (Details) - USD ($) | Aug. 30, 2019 | Dec. 31, 2019 | Dec. 31, 2018 |
Short swing profits | $ 19,799 | $ 23,147 | |
Mr. Bent - Chief Executive Officer [Member] | |||
Short swing profits | $ 178,394 |
Subsequent Events (Narrative) (
Subsequent Events (Narrative) (Details) - USD ($) | May 08, 2020 | May 04, 2020 | Apr. 24, 2020 | Apr. 22, 2020 | Apr. 20, 2020 | Apr. 13, 2020 | Apr. 08, 2020 | Mar. 07, 2020 | Feb. 19, 2020 | Jan. 29, 2020 | Jan. 03, 2020 | Dec. 02, 2019 | Sep. 11, 2019 | Nov. 21, 2018 | Mar. 14, 2018 | Aug. 26, 2019 |
Equity Purchase And Registration Rights Agreement [Member] | ||||||||||||||||
No of shares committed to be issued under the agreement | 600,000 | |||||||||||||||
Subsequent Event [Member] | Equity Purchase And Registration Rights Agreement [Member] | ||||||||||||||||
No of shares committed to be issued under the agreement | 200,000 | 150,000 | 150,000 | 150,000 | 400,000 | |||||||||||
Price per share | $ 0.0551 | $ 0.0581 | $ 0.0685 | $ 0.0748 | $ 0.0807 | |||||||||||
Proceeds from equity purchase agreement | $ 8,283 | $ 5,973 | $ 7,527 | $ 9,593 | $ 32,288 | |||||||||||
Promissory Notes Payable [Member] | MAAB Global Limited (MAAB), Parent Company [Member] | ||||||||||||||||
Debt instrument maximum borrowing capacity | $ 750,000 | |||||||||||||||
Debt instrument maturity date | Feb. 28, 2021 | |||||||||||||||
Promissory Notes Payable [Member] | MAAB Global Limited (MAAB), Parent Company [Member] | Subsequent Event [Member] | ||||||||||||||||
Debt instrument maximum borrowing capacity | $ 1,250,000 | |||||||||||||||
Debt instrument maturity date | Feb. 28, 2022 | |||||||||||||||
8% Senior Secured Convertible Promissory Note [Member] | ||||||||||||||||
Debt instrument maturity date | Jun. 2, 2020 | Jun. 30, 2020 | ||||||||||||||
No of shares issued in conversion of debt | 1,871,515 | |||||||||||||||
Conversion price per share | $ 0.0375 | |||||||||||||||
8% Senior Secured Convertible Promissory Note [Member] | Subsequent Event [Member] | ||||||||||||||||
Value of principal portion of debt converted into shares of common stock | $ 150,000 | $ 16,724 | ||||||||||||||
No of shares issued in conversion of debt | 2,820,874 | 406,908 | ||||||||||||||
Conversion price per share | $ 0.053175 | $ 0.04 | ||||||||||||||
No of shares committed to be issued under the agreement | 250,000 | 200,000 | 200,000 | |||||||||||||
Price per share | $ 0.0449 | $ 0.0515 | $ 0.0515 | |||||||||||||
Proceeds from equity purchase agreement | $ 11,231 | $ 10,305 | $ 10,305 |